FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Malcolm Moore

Research Profile

Anatomy

Living Beings

Physiology

Procedures

Colony Forming Units Assays

Chemicals & Drugs

Disorders

Co-author Network

Publications

TOP 3
Jennifer Lee; Liren Liu; Malcolm A S Moore; Giovanni Morrone; Jae-Hung Shieh; Jianxuan Zhang; Yue Zhang; Jae Yong Eom; Pengbo Zhou
Improved ex vivo expansion of adult hematopoietic stem cells by overcoming CUL4-mediated degradation of HOXB4.
Jennifer J Tsai; Enrico Velardi; Mallory L West; Lauren F Young; Jarrod A Dudakov; Arnab Ghosh; Alan M Hanash; Amanda M Holland; Malcolm A S Moore; Jae-Hung Shieh; Yusuke Shono; Natalie V Singer; Odette M Smith; Koichi Takahashi; Hien T Tran; Marcel R M van den Brink
Nrf2 regulates haematopoietic stem cell function.
Ping Wang; Qiang Zhang; John A Brailsford; Suwei Dong; Ronald C Hendrickson; Karthik Iyer; Malcolm A S Moore; JaeHung Shieh; Steven D Townsend; Samuel J Danishefsky
At last: erythropoietin as a single glycoform.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Malcolm Moore (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jennifer Lee; Liren Liu; Malcolm A S Moore; Giovanni Morrone; Jae-Hung Shieh; Jianxuan Zhang; Yue Zhang; Jae Yong Eom; Pengbo Zhou
Improved ex vivo expansion of adult hematopoietic stem cells by overcoming CUL4-mediated degradation of HOXB4.
Blood 2013;121(20):4082-9.
2013: Jennifer J Tsai; Enrico Velardi; Mallory L West; Lauren F Young; Jarrod A Dudakov; Arnab Ghosh; Alan M Hanash; Amanda M Holland; Malcolm A S Moore; Jae-Hung Shieh; Yusuke Shono; Natalie V Singer; Odette M Smith; Koichi Takahashi; Hien T Tran; Marcel R M van den Brink
Nrf2 regulates haematopoietic stem cell function.
Nature cell biology 2013;15(3):309-16.
2012: Ping Wang; Qiang Zhang; John A Brailsford; Suwei Dong; Ronald C Hendrickson; Karthik Iyer; Malcolm A S Moore; JaeHung Shieh; Steven D Townsend; Samuel J Danishefsky
At last: erythropoietin as a single glycoform.
Angewandte Chemie (International ed. in English) 2012;51(46):11576-84.
2012: Malcolm A S Moore
Waking up HSCs: a new role for E-selectin.
Nature medicine 2012;18(11):1613-4.
2012: Benedikt Bosbach; Elisa de Stanchina; Shayu Deshpande; Katia Manova-Todorova; Malcolm A S Moore; Ferdinand Rossi; Joseph M Scandura; Jae-Hung Shieh; Gunhild Sommer; Darren R Veach; Cristina R Antonescu; Peter Besmer
Imatinib resistance and microcytic erythrocytosis in a KitV558Δ;T669I/+ gatekeeper-mutant mouse model of gastrointestinal stromal tumor.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(34):E2276-83.
2012: Xiangao Huang; David Jayabalan; Jun Liang; Tracey Louie; Malcolm A S Moore; Ruben Niesvizky; Sophia Randolph; Arthur L Shaffer; Louis M Staudt; Jamieson Bretz; Isan Chen; Maurizio Di Liberto; Scott Ely; William C Hahn; Selina Chen-Kiang
Prolonged early G(1) arrest by selective CDK4/CDK6 inhibition sensitizes myeloma cells to cytotoxic killing through cell cycle-coupled loss of IRF4.
Blood 2012;120(5):1095-106.
2012: Emil Lou; Katia Manova-Todorova; Malcolm A S Moore; Yevgeniy Romin; Afsar Barlas; Sho Fujisawa; Subbaya Subramanian
Tunneling Nanotubes: A new paradigm for studying intercellular communication and therapeutics in cancer.
Communicative & integrative biology 2012;5(4):399-403.
2012: Emil Lou; Katia Manova-Todorova; Andre L Moreira; Alexei Morozov; Yevgeniy Romin; Afsar Barlas; Yildirim Dogan; Sho Fujisawa; Sepideh Gholami; Malcolm A S Moore
Tunneling nanotubes provide a unique conduit for intercellular transfer of cellular contents in human malignant pleural mesothelioma.
PloS one 2012;7(3):e33093.
2011: Nicolas Lecomte; Malcolm A S Moore; Pavel Nagorny; Jon T Njardarson; Ouathek Ouerfelli; Guangli Yang; Robert Downey; Samuel J Danishefsky
Emergence of potent inhibitors of metastasis in lung cancer via syntheses based on migrastatin.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(37):15074-8.
2011: Tiziana Mega; Maria Mesuraca; Malcolm A S Moore; Valter Agosti; Nicola Amodio; Heather M Bond; Emanuela Chiarella; Michele Grieco; Sarah J Horton; Michela Lupia; Daniela Pelaggi; Jan Jacob Schuringa; Raffaella Spina; Giovanni Morrone
Zinc finger protein 521 antagonizes early B-cell factor 1 and modulates the B-lymphoid differentiation of primary hematopoietic progenitors.
Cell cycle (Georgetown, Tex.) 2011;10(13):2129-39.
2011: Tatsuyoshi Funasaka; Hiroshi Nakano; Yu Wu; Chieko Hashizume; Ling Gu; Takuro Nakamura; Wei Wang; Pengbo Zhou; Malcolm A S Moore; Hiroshi Sato; Richard W Wong
RNA export factor RAE1 contributes to NUP98-HOXA9-mediated leukemogenesis.
Cell cycle (Georgetown, Tex.) 2011;10(9):1456-67.
2010: Alexei Morozov; Robert J Downey; John Healey; Andre L Moreira; Emil Lou; Anna Franceschino; Yildirim Dogan; Roland Leung; Mark A Edgar; Michael P LaQuaglia; ROBERT G MAKI; Malcolm A S Moore
Benign mesenchymal stromal cells in human sarcomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(23):5630-40.
2010: Lamis K Eldjerou; Sonali Chaudhury; Ada Baisre-de Leon; Mai He; Maria E Arcila; Glenn Heller; Richard J O'Reilly; Juliet N Barker; Malcolm A S Moore
An in vivo model of double-unit cord blood transplantation that correlates with clinical engraftment.
Blood 2010;116(19):3999-4006.
2010: Malcolm A S Moore
A cancer fate in the hands of a samurai.
Nature medicine 2010;16(9):963-5.
2010: Katja C Weisel; Hans-Georg Kopp; Malcolm A S Moore; Lorenz Studer; Tiziano Barberi
Wnt1 overexpression leads to enforced cardiomyogenesis and inhibition of hematopoiesis in murine embryonic stem cells.
Stem cells and development 2010;19(5):745-51.
2010: Thordur Oskarsson; Pavel Nagorny; Isaac J Krauss; Lucy Perez; Mihirbaran Mandal; Guangli Yang; Ouathek Ouerfelli; Danhua Xiao; Malcolm A S Moore; Joan Massagué; Samuel J Danishefsky
Diverted total synthesis leads to the generation of promising cell-migration inhibitors for treatment of tumor metastasis: in vivo and mechanistic studies on the migrastatin core ether analog.
Journal of the American Chemical Society 2010;132(9):3224-8.
2010: Yasuhiko Miyata; Yan Liu; Vladimir Jankovic; Goro Sashida; Jennifer May Lee; Jae-Hung Shieh; Tomoki Naoe; Malcolm A S Moore; Stephen D Nimer
Cyclin C regulates human hematopoietic stem/progenitor cell quiescence.
Stem cells (Dayton, Ohio) 2010;28(2):308-17.
2010: Shayu Deshpande; Valter Agosti; Katia Manova-Todorova; Malcolm A S Moore; Matthew P Hardy; Peter Besmer
Kit ligand cytoplasmic domain is essential for basolateral sorting in vivo and has roles in spermatogenesis and hematopoiesis.
Developmental biology 2010;337(2):199-210.
2009: David C Dorn; Cynthia A Kou; Kim J Png; Malcolm A S Moore
The effect of cantharidins on leukemic stem cells.
International journal of cancer. Journal international du cancer 2009;124(9):2186-99.
2009: Katja C Weisel; Malcolm A S Moore; Lothar Kanz; Robert Möhle
Extended in vitro expansion of adult, mobilized CD34+ cells without significant cell senescence using a stromal cell coculture system with single cytokine support.
Stem cells and development 2009;18(2):229-34.
2009: Xiaomin Zheng; Claudia Oancea; Reinhard Henschler; Malcolm A S Moore; Martin Ruthardt
Reciprocal t(9;22) ABL/BCR fusion proteins: leukemogenic potential and effects on B cell commitment.
PloS one 2009;4(10):e7661.
2008: Gabsang Lee; Byung Soo Kim; Jae-Hung Sheih; Malcolm A S Moore
Forced expression of HoxB4 enhances hematopoietic differentiation by human embryonic stem cells.
Molecules and cells 2008;25(4):487-93.
2008: Heather M Bond; Maria Mesuraca; Nicola Amodio; Tiziana Mega; Valter Agosti; Delia Fanello; Daniela Pelaggi; Lars Bullinger; Michele Grieco; Malcolm A S Moore; Salvatore Venuta; Giovanni Morrone
Early hematopoietic zinc finger protein-zinc finger protein 521: a candidate regulator of diverse immature cells.
The international journal of biochemistry & cell biology 2008;40(5):848-54.
2007: Kitai Kim; Kitwa Ng; Peter J Rugg-Gunn; Jae-Hung Shieh; Oktay Kirak; Rudolf Jaenisch; Teruhiko Wakayama; Malcolm A S Moore; Roger A Pedersen; George Q Daley
Recombination signatures distinguish embryonic stem cells derived by parthenogenesis and somatic cell nuclear transfer.
Cell stem cell 2007;1(3):346-52.
2007: Shijiang Lu; Qiang Feng; Sergio Caballero; Yu Chen; Malcolm A S Moore; Maria B Grant; Robert Lanza
Generation of functional hemangioblasts from human embryonic stem cells.
Nature methods 2007;4(6):501-9.
2007: Malcolm A S Moore; Ki Young Chung; Magdalena Plasilova; Jan Jacob Schuringa; Jae-Hung Shieh; Pengbo Zhou; Giovanni Morrone
NUP98 dysregulation in myeloid leukemogenesis.
Annals of the New York Academy of Sciences 2007;1106():114-42.
2007: Malcolm A S Moore; David C Dorn; Jan Jacob Schuringa; Ki Young Chung; Giovanni Morrone
Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
Experimental hematology 2007;35(4 Suppl 1):105-16.
2007: Kai-Da Wu; Li Zhou; Douglas Burtrum; Dale L Ludwig; Malcolm A S Moore
Antibody targeting of the insulin-like growth factor I receptor enhances the anti-tumor response of multiple myeloma to chemotherapy through inhibition of tumor proliferation and angiogenesis.
Cancer immunology, immunotherapy : CII 2007;56(3):343-57.
2007: Angie R Angeles; David C Dorn; Cynthia A Kou; Malcolm A S Moore; Samuel J Danishefsky
Total synthesis of peribysin E necessitates revision of the assignment of its absolute configuration.
Angewandte Chemie (International ed. in English) 2007;46(9):1451-4.
2006: Ki Young Chung; Giovanni Morrone; Jan Jacob Schuringa; Magdalena Plasilova; Jae-Hung Shieh; Yue Zhang; Pengbo Zhou; Malcolm A S Moore
Enforced expression of NUP98-HOXA9 in human CD34(+) cells enhances stem cell proliferation.
Cancer research 2006;66(24):11781-91.
2006: Victoria W Wen; Kaida Wu; Sheik Baksh; Rebecca A Hinshelwood; Richard B Lock; Susan J Clark; Malcolm A S Moore; Karen L MacKenzie
Telomere-driven karyotypic complexity concurs with p16INK4a inactivation in TP53-competent immortal endothelial cells.
Cancer research 2006;66(22):10691-700.
2006: Katja C Weisel; Ying Gao; Jae-Hung Shieh; Malcolm A S Moore
Stromal cell lines from the aorta-gonado-mesonephros region are potent supporters of murine and human hematopoiesis.
Experimental hematology 2006;34(11):1505-16.
2006: Linda B. Baughn; Maurizio Di Liberto; Kaida Wu; Peter L Toogood; Tracey Louie; Rachel Gottschalk; Ruben Niesvizky; Hearn Cho; Scott Ely; Malcolm A S Moore; Selina Chen-Kiang
A novel orally active small molecule potently induces G1 arrest in primary myeloma cells and prevents tumor growth by specific inhibition of cyclin-dependent kinase 4/6.
Cancer research 2006;66(15):7661-7.
2006: Wei He; David C Dorn; Hediye Erdjument-Bromage; Paul Tempst; Malcolm A S Moore; Joan Massagué
Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway.
Cell 2006;125(5):929-41.
2006: Anja Moldenhauer; Malcolm A S Moore; Kerstin Schmidt; Holger Kiesewetter; Abdulgabar Salama
Differences in the transmigration of different dendritic cells.
Experimental hematology 2006;34(6):745-52.
2006: Albertus T J Wierenga; Hein Schepers; Malcolm A S Moore; Edo Vellenga; Jan Jacob Schuringa
STAT5-induced self-renewal and impaired myelopoiesis of human hematopoietic stem/progenitor cells involves down-modulation of C/EBPalpha.
Blood 2006;107(11):4326-33.
2006: Malcolm A S Moore; Jae-Hung Shieh; Gabsang Lee
Hematopoietic cells.
Methods in enzymology 2006;418():208-42.
2005: Pierre Feugier; Na Li; Deog-Yeon Jo; Jae-Hung Shieh; Karen L MacKenzie; J F Lesesve; Véronique Latger-Cannard; Danièle Bensoussan; Helen-Ann Brown Epstein; Shahin Rafii; J F Stoltz; Malcolm A S Moore
Osteopetrotic mouse stroma with thrombopoietin, c-kit ligand, and flk-2 ligand supports long-term mobilized CD34+ hematopoiesis in vitro.
Stem cells and development 2005;14(5):505-16.
2005: Kai-Da Wu; Young Shin Cho; Jonathan Katz; Vladimir Ponomarev; Selina Chen-Kiang; Samuel J Danishefsky; Malcolm A S Moore
Investigation of antitumor effects of synthetic epothilone analogs in human myeloma models in vitro and in vivo.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(30):10640-5.
2005: Malcolm A S Moore
Converging pathways in leukemogenesis and stem cell self-renewal.
Experimental hematology 2005;33(7):719-37.
2005: Katja C Weisel; Malcolm A S Moore
Genetic and functional characterization of isolated stromal cell lines from the aorta-gonado-mesonephros region.
Annals of the New York Academy of Sciences 2005;1044():51-9.
2005: Robert Lanza; Jae-Hung Shieh; Peter J Wettstein; Raymond W Sweeney; Kaida Wu; Anat Weisz; Nancy D Borson; Boyd Henderson; Michael D West; Malcolm A S Moore
Long-term bovine hematopoietic engraftment with clone-derived stem cells.
Cloning and stem cells 2005;7(2):95-106.
2005: Kai-da Wu; Malcolm A S Moore
Determination of telomerase activity and telomere length.
Methods in molecular medicine 2005;113():207-23.
2005: Ki Young Chung; Giovanni Morrone; Jan Jacob Schuringa; Bryan Wong; David C Dorn; Malcolm A S Moore
Enforced expression of an Flt3 internal tandem duplication in human CD34+ cells confers properties of self-renewal and enhanced erythropoiesis.
Blood 2005;105(1):77-84.
2004: Eunice S Wang; Julie T Feldstein; Yan Wu; Zhenping Zhu; Daniel J Hicklin; Malcolm A S Moore
Targeting autocrine and paracrine VEGF receptor pathways inhibits human lymphoma xenografts in vivo.
Blood 2004;104(9):2893-902.
2004: Christoph Gaul; Jon T Njardarson; Dandan Shan; David C Dorn; Kai-Da Wu; William P Tong; Xin-Yun Huang; Malcolm A S Moore; Samuel J Danishefsky
The migrastatin family: discovery of potent cell migration inhibitors by chemical synthesis.
Journal of the American Chemical Society 2004;126(36):11326-37.
2004: Jan Jacob Schuringa; Ki Young Chung; Giovanni Morrone; Malcolm A S Moore
Constitutive activation of STAT5A promotes human hematopoietic stem cell self-renewal and erythroid differentiation.
The Journal of experimental medicine 2004;200(5):623-35.
2004: Tulin Budak-Alpdogan; Onder Alpdogan; Debabrata Banerjee; Eunice S Wang; Malcolm A S Moore; Joseph R Bertino
Methotrexate and cytarabine inhibit progression of human lymphoma in NOD/SCID mice carrying a mutant dihydrofolate reductase and cytidine deaminase fusion gene.
Molecular therapy : the journal of the American Society of Gene Therapy 2004;10(3):574-84.
2004: Anja Moldenhauer; Richard C Frank; Javier Pinilla-Ibarz; Gudrun Holland; Piernicola Boccuni; David A Scheinberg; Abdulgabar Salama; Karl Seeger; Malcolm A S Moore; Stephen D Nimer
Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1-containing fusion proteins.
Journal of leukocyte biology 2004;76(3):623-33.
2004: Loretta Gammaitoni; Katja C Weisel; Monica Gunetti; Kai-Da Wu; Stefania Bruno; Silvana Pinelli; Antonio Bonati; Massimo Aglietta; Malcolm A S Moore; Wanda Piacibello
Elevated telomerase activity and minimal telomere loss in cord blood long-term cultures with extensive stem cell replication.
Blood 2004;103(12):4440-8.
2004: Stephen D Nimer; Malcolm A S Moore
Effects of the leukemia-associated AML1-ETO protein on hematopoietic stem and progenitor cells.
Oncogene 2004;23(24):4249-54.
2004: Robert Lanza; Malcolm A S Moore; Teruhiko Wakayama; Anthony C F Perry; Jae-Hung Shieh; Jan Hendrikx; Annarosa Leri; Stefano Chimenti; Alyssa Monsen; Daria Nurzynska; Michael D West; Jan Kajstura; Piero Anversa
Regeneration of the infarcted heart with stem cells derived by nuclear transplantation.
Circulation research 2004;94(6):820-7.
2004: Q Ye; Jae-Hung Shieh; Giovanni Morrone; Malcolm A S Moore
Expression of constitutively active Notch4 (Int-3) modulates myeloid proliferation and differentiation and promotes expansion of hematopoietic progenitors.
Leukemia 2004;18(4):777-87.
2004: Valter Agosti; Selim Corbacioglu; Imke Ehlers; Claudia Waskow; Gunhild Sommer; Georgina Berrozpe; Holger Kissel; Christine M Tucker; Katia Manova-Todorova; Malcolm A S Moore; Hans-Reimer Rodewald; Peter Besmer
Critical role for Kit-mediated Src kinase but not PI 3-kinase signaling in pro T and pro B cell development.
The Journal of experimental medicine 2004;199(6):867-78.
2004: Heather M Bond; Maria Mesuraca; Ennio Carbone; Patrizia Bonelli; Valter Agosti; Nicola Amodio; Gaetano De Rosa; Massimo Di Nicola; ALESSANDRO MASSIMO GIANNI; Malcolm A S Moore; Akiko Hata; Michele Grieco; Giovanni Morrone; Salvatore Venuta
Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cells.
Blood 2004;103(6):2062-70.
2004: Lia E Perez; Onder Alpdogan; Jae-Hung Shieh; Donald Wong; Ahmed Merzouk; Hassan Salari; Richard J O'Reilly; Marcel R M van den Brink; Malcolm A S Moore
Increased plasma levels of stromal-derived factor-1 (SDF-1/CXCL12) enhance human thrombopoiesis and mobilize human colony-forming cells (CFC) in NOD/SCID mice.
Experimental hematology 2004;32(3):300-7.
2004: Malcolm A S Moore
Commentary: the role of cell migration in the ontogeny of the lymphoid system.
Stem cells and development 2004;13(1):1-21.
2004: Jan Jacob Schuringa; Kaida Wu; Giovanni Morrone; Malcolm A S Moore
Enforced activation of STAT5A facilitates the generation of embryonic stem-derived hematopoietic stem cells that contribute to hematopoiesis in vivo.
Stem cells (Dayton, Ohio) 2004;22(7):1191-204.
2004: Anja Moldenhauer; J-H Shieh; A Pruss; Abdulgabar Salama; Malcolm A S Moore
Tumor necrosis factor alpha enhances the adenoviral transduction of CD34+ hematopoietic progenitor cells.
Stem cells (Dayton, Ohio) 2004;22(3):283-91.
2004: Anja Moldenhauer; Marcelo Nociari; George Lam; Abdulgabar Salama; Shahin Rafii; Malcolm A S Moore
Tumor necrosis factor alpha-stimulated endothelium: an inducer of dendritic cell development from hematopoietic progenitors and myeloid leukemic cells.
Stem cells (Dayton, Ohio) 2004;22(2):144-57.
2004: Eunice S Wang; Kaida Wu; Allison C Chin; Selina Chen-Kiang; Krisztina Pongracz; Sergei Gryaznov; Malcolm A S Moore
Telomerase inhibition with an oligonucleotide telomerase template antagonist: in vitro and in vivo studies in multiple myeloma and lymphoma.
Blood 2004;103(1):258-66.
2003: James C Mulloy; Jörg Cammenga; Francisco J Berguido; Kaida Wu; Ping Zhou; Raymond Comenzo; Suresh C Jhanwar; Malcolm A S Moore; Stephen D Nimer
Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element.
Blood 2003;102(13):4369-76.
2003: Yue Zhang; Giovanni Morrone; Jianxuan Zhang; Xiaoai Chen; Xiaoling Lu; Liang Ma; Malcolm A S Moore; Pengbo Zhou
CUL-4A stimulates ubiquitylation and degradation of the HOXA9 homeodomain protein.
The EMBO journal 2003;22(22):6057-67.
2003: Tiziano Barberi; Peter Klivenyi; Noel Y Calingasan; Hyojin Lee; Hibiki Kawamata; Kathleen Loonam; Anselme L Perrier; Juan Bruses; Maria E Rubio; Norbert Topf; Vivian S Tabar; Neil L Harrison; M Flint Beal; Malcolm A S Moore; Studer Lorenz
Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice.
Nature biotechnology 2003;21(10):1200-7.
2003: Kai-Da Wu; Lisa M Orme; John Shaughnessy; Joth Jacobson; Bart Barlogie; Malcolm A S Moore
Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival.
Blood 2003;101(12):4982-9.
2003: Eunice S Wang; Owen A O'Connor; Yuhong She; Andrew D Zelenetz; Francis M Sirotnak; Malcolm A S Moore
Activity of a novel anti-folate (PDX, 10-propargyl 10-deazaaminopterin) against human lymphoma is superior to methotrexate and correlates with tumor RFC-1 gene expression.
Leukemia & lymphoma 2003;44(6):1027-35.
2003: Gunhild Sommer; Valter Agosti; Imke Ehlers; Ferdinand Rossi; Selim Corbacioglu; Judith Farkas; Malcolm A S Moore; Katia Manova-Todorova; Cristina R Antonescu; Peter Besmer
Gastrointestinal stromal tumors in a mouse model by targeted mutation of the Kit receptor tyrosine kinase.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(11):6706-11.
2003: Shahin Rafii; Scott T Avecilla; Sergey V Shmelkov; Koji Shido; Rafael Tejada; Malcolm A S Moore; Beate Heissig; Koichi Hattori
Angiogenic factors reconstitute hematopoiesis by recruiting stem cells from bone marrow microenvironment.
Annals of the New York Academy of Sciences 2003;996():49-60.
2003: Anja Moldenhauer; Marcelo Nociari; S Dias; P Lalezari; Malcolm A S Moore
Optimized culture conditions for the generation of dendritic cells from peripheral blood monocytes.
Vox sanguinis 2003;84(3):228-36.
2003: Sonia Franco; M Fevzi Ozkaynak; Claudio Sandoval; Oya Tugal; Somasundaram Jayabose; M Engelhardt; Malcolm A S Moore
Telomere dynamics in childhood leukemia and solid tumors: a follow-up study.
Leukemia 2003;17(2):401-10.
2002: Koichi Hattori; Beate Heissig; Yan Wu; Sergio Dias; Rafael Tejada; Barbara Ferris; Daniel J Hicklin; Zhenping Zhu; Peter Bohlen; Larry Witte; Jan Hendrikx; Neil R Hackett; Helen-Ann Brown Epstein; Malcolm A S Moore; Zena Werb; David Lyden; Shahin Rafii
Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment.
Nature medicine 2002;8(8):841-9.
2002: Karen L MacKenzie; Sonia Franco; Afzal J Naiyer; Chad May; Michel Sadelain; Shahin Rafii; Malcolm A S Moore
Multiple stages of malignant transformation of human endothelial cells modelled by co-expression of telomerase reverse transcriptase, SV40 T antigen and oncogenic N-ras.
Oncogene 2002;21(27):4200-11.
2002: Beate Heissig; Koichi Hattori; Sergio Dias; Matthias Friedrich; Barbara Ferris; Neil R Hackett; Helen-Ann Brown Epstein; Peter Besmer; David Lyden; Malcolm A S Moore; Zena Werb; Shahin Rafii
Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand.
Cell 2002;109(5):625-37.
2002: Jessica Boklan; Gouri Nanjangud; Karen L MacKenzie; Chad May; Michel Sadelain; Malcolm A S Moore
Limited proliferation and telomere dysfunction following telomerase inhibition in immortal murine fibroblasts.
Cancer research 2002;62(7):2104-14.
2002: Naoko Takebe; Li-Cheng Xu; Karen L MacKenzie; Joseph R Bertino; Malcolm A S Moore
Methotrexate selection of long-term culture initiating cells following transduction of CD34(+) cells with a retrovirus containing a mutated human dihydrofolate reductase gene.
Cancer gene therapy 2002;9(3):308-20.
2002: Pierre Feugier; Deog-Yeon Jo; Jae-Hung Shieh; Karen L MacKenzie; Shahin Rafii; Helen-Ann Brown Epstein; Malcolm A S Moore
Ex vivo expansion of stem and progenitor cells in co-culture of mobilized peripheral blood CD34+ cells on human endothelium transfected with adenovectors expressing thrombopoietin, c-kit ligand, and Flt-3 ligand.
Journal of hematotherapy & stem cell research 2002;11(1):127-38.
2002: Malcolm A S Moore
Putting the neo into neoangiogenesis.
The Journal of clinical investigation 2002;109(3):313-5.
2002: Malcolm A S Moore
Cytokine and chemokine networks influencing stem cell proliferation, differentiation, and marrow homing.
Journal of cellular biochemistry. Supplement 2002;38():29-38.
2002: James C Mulloy; Jörg Cammenga; Karen L MacKenzie; Francisco J Berguido; Malcolm A S Moore; Stephen D Nimer
The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells.
Blood 2002;99(1):15-23.
2001: William J Lane; K Hattori; Sergio Dias; E I Peerschke; Malcolm A S Moore; D L Blanset; P C Lang; M Petrone; Shahin Rafii
Anagrelide metabolite induces thrombocytopenia in mice by inhibiting megakaryocyte maturation without inducing platelet aggregation.
Experimental hematology 2001;29(12):1417-24.
2001: David Lyden; K Hattori; Sergio Dias; C Costa; Pamela Blaikie; Linda J Butros; Amy Chadburn; Beate Heissig; W Marks; Larry Witte; Y Wu; Daniel J Hicklin; Z Zhu; Neil R Hackett; Helen-Ann Brown Epstein; Malcolm A S Moore; K A Hajjar; Katia Manova-Todorova; Robert Benezra; Shahin Rafii
Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth.
Nature medicine 2001;7(11):1194-201.
2001: Sergio Dias; Koichi Hattori; Beate Heissig; Z Zhu; Y Wu; Larry Witte; Daniel J Hicklin; M Tateno; Peter Bohlen; Malcolm A S Moore; Shahin Rafii
Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(19):10857-62.
2001: Malcolm A S Moore
The role of chemoattraction in cancer metastases.
BioEssays : news and reviews in molecular, cellular and developmental biology 2001;23(8):674-6.
2001: Sonia Franco; Karen L MacKenzie; Sergio Dias; S Alvarez; Shahin Rafii; Malcolm A S Moore
Clonal variation in phenotype and life span of human embryonic fibroblasts (MRC-5) transduced with the catalytic component of telomerase (hTERT).
Experimental cell research 2001;268(1):14-25.
2001: Malcolm A S Moore; K Hattori; Beate Heissig; Jae-Hung Shieh; Sergio Dias; Helen-Ann Brown Epstein; Shahin Rafii
Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1.
Annals of the New York Academy of Sciences 2001;938():36-45; discussion 45-7.
2001: K Hattori; Beate Heissig; K Tashiro; T Honjo; M Tateno; Jae-Hung Shieh; Neil R Hackett; M S Quitoriano; Helen-Ann Brown Epstein; Shahin Rafii; Malcolm A S Moore
Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells.
Blood 2001;97(11):3354-60.
2001: K Hattori; Sergio Dias; Beate Heissig; Neil R Hackett; David Lyden; M Tateno; Daniel J Hicklin; Z Zhu; Larry Witte; R G Crystal; Malcolm A S Moore; Shahin Rafii
Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells.
The Journal of experimental medicine 2001;193(9):1005-14.
2000: William J Lane; Sergio Dias; K Hattori; Beate Heissig; Margaret Choy; Sina Y Rabbany; J Wood; Malcolm A S Moore; Shahin Rafii
Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases.
Blood 2000;96(13):4152-9.
2000: T Kikuchi; N Miyazawa; Malcolm A S Moore; Helen-Ann Brown Epstein
Tumor regression induced by intratumor administration of adenovirus vector expressing CD40 ligand and naive dendritic cells.
Cancer research 2000;60(22):6391-5.
2000: T Kikuchi; Stefan Worgall; R Singh; Malcolm A S Moore; Helen-Ann Brown Epstein
Dendritic cells genetically modified to express CD40 ligand and pulsed with antigen can initiate antigen-specific humoral immunity independent of CD4+ T cells.
Nature medicine 2000;6(10):1154-9.
2000: Karen L MacKenzie; Sonia Franco; Chad May; Michel Sadelain; Malcolm A S Moore
Mass cultured human fibroblasts overexpressing hTERT encounter a growth crisis following an extended period of proliferation.
Experimental cell research 2000;259(2):336-50.
2000: Sergio Dias; K Hattori; Z Zhu; Beate Heissig; Margaret Choy; William Stratton Lane; Y Wu; Amy Chadburn; Elizabeth Hyjek; M Gill; Daniel J Hicklin; Larry Witte; Malcolm A S Moore; Shahin Rafii
Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration.
The Journal of clinical investigation 2000;106(4):511-21.
2000: Karen L MacKenzie; Neil R Hackett; Helen-Ann Brown Epstein; Malcolm A S Moore
Adenoviral vector-mediated gene transfer to primitive human hematopoietic progenitor cells: assessment of transduction and toxicity in long-term culture.
Blood 2000;96(1):100-8.
2000: T Kikuchi; Malcolm A S Moore; Helen-Ann Brown Epstein
Dendritic cells modified to express CD40 ligand elicit therapeutic immunity against preexisting murine tumors.
Blood 2000;96(1):91-9.
2000: T Fushimi; A Kojima; Malcolm A S Moore; Helen-Ann Brown Epstein
Macrophage inflammatory protein 3alpha transgene attracts dendritic cells to established murine tumors and suppresses tumor growth.
The Journal of clinical investigation 2000;105(10):1383-93.
2000: Malcolm A S Moore
Umbilical cord blood: an expandable resource.
The Journal of clinical investigation 2000;105(7):855-6.
2000: W Han; Q Ye; Malcolm A S Moore
A soluble form of human Delta-like-1 inhibits differentiation of hematopoietic progenitor cells.
Blood 2000;95(5):1616-25.
2000: M Engelhardt; K Mackenzie; P Drullinsky; R T Silver; Malcolm A S Moore
Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
Cancer research 2000;60(3):610-7.
2000: M Peichev; A J Naiyer; D Pereira; Z Zhu; William J Lane; M Williams; Mehmet C Oz; Daniel J Hicklin; Larry Witte; Malcolm A S Moore; Shahin Rafii
Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors.
Blood 2000;95(3):952-8.
2000: D Y Jo; Shahin Rafii; T Hamada; Malcolm A S Moore
Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1.
The Journal of clinical investigation 2000;105(1):101-11.
1999: A J Naiyer; D Y Jo; J Ahn; R Mohle; M Peichev; G Lam; R L Silverstein; Malcolm A S Moore; Shahin Rafii
Stromal derived factor-1-induced chemokinesis of cord blood CD34(+) cells (long-term culture-initiating cells) through endothelial cells is mediated by E-selectin.
Blood 1999;94(12):4011-9.
1999: Malcolm A S Moore
"Turning brain into blood"--clinical applications of stem-cell research in neurobiology and hematology.
The New England journal of medicine 1999;341(8):605-7.
1999: Joan Albanell; George J Bosl; Victor E Reuter; M Engelhardt; Sonia Franco; Malcolm A S Moore; Ethan Dmitrovsky
Telomerase activity in germ cell cancers and mature teratomas.
Journal of the National Cancer Institute 1999;91(15):1321-6.
1999: RV Deshpande; P Lalezari; Robert Pergolizzi; Malcolm A S Moore
Structural abnormalities in the G-CSF receptor in severe congenital neutropenia.
Journal of hematotherapy & stem cell research 1999;8(4):411-20.
1999: Robert Möhle; F Bautz; Shahin Rafii; Malcolm A S Moore; Wolfram Brugger; Lothar Kanz
Regulation of transendothelial migration of hematopoietic progenitor cells.
Annals of the New York Academy of Sciences 1999;872():176-85; discussion 185-6.
1999: Stefan Worgall; R Singh; Philip L Leopold; Robert J Kaner; Neil R Hackett; N Topf; Malcolm A S Moore; Helen-Ann Brown Epstein
Selective expansion of alveolar macrophages in vivo by adenovirus-mediated transfer of the murine granulocyte-macrophage colony-stimulating factor cDNA.
Blood 1999;93(2):655-66.
1999: Malcolm A S Moore; K L MacKenzie
Optimizing conditions for gene transfer into human hematopoietic cells.
Progress in experimental tumor research 1999;36():20-49.
1998: B M Frey; Shahin Rafii; Helen-Ann Brown Epstein; Malcolm A S Moore
[Adenovirus long-term expression of thrombopoietin in vivo: a new model for myeloproliferative syndrome and osteomyelofibrosis].
Schweizerische medizinische Wochenschrift 1998;128(42):1587-92.
1998: Y Tajima; Malcolm A S Moore; V da C Soares; M Ono; Holger Kissel; Peter Besmer
Consequences of exclusive expression in vivo of Kit-ligand lacking the major proteolytic cleavage site.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(20):11903-8.
1998: T Hamada; R Möhle; Joseph Hesselgesser; James A Hoxie; RL Nachman; Malcolm A S Moore; Shahin Rafii
Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1 (SDF-1) enhances platelet formation.
The Journal of experimental medicine 1998;188(3):539-48.
1998: RV Deshpande; RH Peterson; Malcolm A S Moore
Granulocyte colony-stimulating factor activates protein kinase A in granulocytic but not monocytic precursors or neutrophils.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1998;18(8):579-86.
1998: K Narumi; M Suzuki; W Song; Malcolm A S Moore; Helen-Ann Brown Epstein
Intermittent, repetitive corticosteroid-induced upregulation of platelet levels after adenovirus-mediated transfer to the liver of a chimeric glucocorticoid-responsive promoter controlling the thrombopoietin cDNA.
Blood 1998;92(3):822-33.
1998: Qun Shi; Shahin Rafii; MH Wu; Errol S Wijelath; C Yu; Atsushi Ishida; Y Fujita; S Kothari; R Mohle; Lester R Sauvage; Malcolm A S Moore; R F Storb; William P Hammond
Evidence for circulating bone marrow-derived endothelial cells.
Blood 1998;92(2):362-7.
1998: Robert Möhle; F Bautz; Shahin Rafii; Malcolm A S Moore; Wolfram Brugger; Lothar Kanz
The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1.
Blood 1998;91(12):4523-30.
1998: M Suzuki; R Singh; Malcolm A S Moore; WR Song; Helen-Ann Brown Epstein
Similarity of strain- and route-dependent murine responses to an adenovirus vector using the homologous thrombopoietin cDNA as the reporter genes.
Human gene therapy 1998;9(8):1223-31.
1998: Y Tajima; E J Huang; Keith Vosseller; M Ono; Malcolm A S Moore; Peter Besmer
Role of dimerization of the membrane-associated growth factor kit ligand in juxtacrine signaling: the Sl17H mutation affects dimerization and stability-phenotypes in hematopoiesis.
The Journal of experimental medicine 1998;187(9):1451-61.
1998: B M Frey; Neil R Hackett; J M Bergelson; R Finberg; Helen-Ann Brown Epstein; Malcolm A S Moore; Shahin Rafii
High-efficiency gene transfer into ex vivo expanded human hematopoietic progenitors and precursor cells by adenovirus vectors.
Blood 1998;91(8):2781-92.
1998: Susan F Slovin; Howard I Scher; Chaitanya R Divgi; Victor E Reuter; George Sgouros; Malcolm A S Moore; K Weingard; R Pettengall; M Imbriaco; AM el-Shirbiny; Ronald Finn; J Bronstein; C Brett; D Milenic; Ann M Dnistrian; L Shapiro; J Schlom; Steven M Larson
Interferon-gamma and monoclonal antibody 131I-labeled CC49: outcomes in patients with androgen-independent prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(3):643-51.
1998: B M Frey; Shahin Rafii; M Teterson; D Eaton; Helen-Ann Brown Epstein; Malcolm A S Moore
Adenovector-mediated expression of human thrombopoietin cDNA in immune-compromised mice: insights into the pathophysiology of osteomyelofibrosis.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(2):691-9.
1998: R Möhle; Shahin Rafii; Malcolm A S Moore
The role of endothelium in the regulation of hematopoietic stem cell migration.
Stem cells (Dayton, Ohio) 1998;16 Suppl 1():159-65.
1998: RV Deshpande; Malcolm A S Moore
G-CSF receptor-mediated up-regulation of c-fos but not c-raf mRNA expression in myeloid cells.
Molecular and cellular biochemistry 1998;178(1-2):47-50.
1998: M Flasshove; D Banerjee; J P Leonard; Shin Mineishi; M X Li; J R Bertino; Malcolm A S Moore
Retroviral transduction of human CD34+ umbilical cord blood progenitor cells with a mutated dihydrofolate reductase cDNA.
Human gene therapy 1998;9(1):63-71.
1998: M Engelhardt; M Fevzi Ozkaynak; P Drullinsky; Claudio Sandoval; Oya Tugal; Somasundaram Jayabose; Malcolm A S Moore
Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy.
Leukemia 1998;12(1):13-24.
1997: R Möhle; P Salemi; Malcolm A S Moore; Shahin Rafii
Expression of interleukin-5 by human bone marrow microvascular endothelial cells: implications for the regulation of eosinophilopoiesis in vivo.
British journal of haematology 1997;99(4):732-8.
1997: J Albanell; Fulvio Lonardo; Valerie W Rusch; M Engelhardt; John Langenfeld; W Han; David S Klimstra; Venkatraman E Seshan; Malcolm A S Moore; Ethan Dmitrovsky
High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage.
Journal of the National Cancer Institute 1997;89(21):1609-15.
1997: M Engelhardt; P Drullinsky; Jose G Guillem; Malcolm A S Moore
Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(11):1931-41.
1997: Shahin Rafii; R Mohle; F Shapiro; B M Frey; Malcolm A S Moore
Regulation of hematopoiesis by microvascular endothelium.
Leukemia & lymphoma 1997;27(5-6):375-86.
1997: W Song; HL Kong; H Carpenter; H Torii; Richard D Granstein; Shahin Rafii; Malcolm A S Moore; Helen-Ann Brown Epstein
Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity.
The Journal of experimental medicine 1997;186(8):1247-56.
1997: M Engelhardt; J Albanell; P Drullinsky; W Han; Jose G Guillem; Howard I Scher; Victor E Reuter; Malcolm A S Moore
Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(10):1849-57.
1997: Guido Dalbagni; W Han; Zuo-Feng Zhang; Carlos Cordon-Cardo; Patricia E Saigo; William R Fair; Harry W Herr; Nam W Kim; Malcolm A S Moore
Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(9):1593-8.
1997: F Shapiro; Tzy-Jyun Yao; Craig Moskowitz; Lilian Reich; David Wuest; S Heimfeld; Ian K McNiece; JL Gabrilove; Stephen D Nimer; Malcolm A S Moore
Effects of prior therapy on the in vitro proliferative potential of stem cell factor plus filgrastim-mobilized CD34-positive progenitor cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(9):1571-8.
1997: RV Deshpande; RH Peterson; Malcolm A S Moore
Granulocyte colony-stimulating factor-induced activation of protein kinase-C in myeloid cells.
Journal of cellular biochemistry 1997;66(3):286-96.
1997: K Nason-Burchenal; W Maerz; J Albanell; J Allopenna; P Martin; Malcolm A S Moore; Ethan Dmitrovsky
Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
Differentiation; research in biological diversity 1997;61(5):321-31.
1997: M Engelhardt; R Kumar; J Albanell; R Pettengell; W Han; Malcolm A S Moore
Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells.
Blood 1997;90(1):182-93.
1997: S J Cannizzo; B M Frey; S Raffi; Malcolm A S Moore; D Eaton; M Suzuki; R Singh; Charles A Mack; Helen-Ann Brown Epstein
Augmentation of blood platelet levels by intratracheal administration of an adenovirus vector encoding human thrombopoietin cDNA.
Nature biotechnology 1997;15(6):570-3.
1997: R Möhle; D Green; Malcolm A S Moore; RL Nachman; Shahin Rafii
Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(2):663-8.
1997: Malcolm A S Moore
Stem cell proliferation: ex vivo and in vivo observations.
Stem cells (Dayton, Ohio) 1997;15 Suppl 1():239-48; discussion 248-51.
1997: P Szabolcs; D H Ciocon; Malcolm A S Moore; James W Young
Growth and differentiation of human dendritic cells from CD34+ progenitors.
Advances in experimental medicine and biology 1997;417():15-9.
1997: RV Deshpande; RH Peterson; Malcolm A S Moore
Protein tyrosine kinases in granulocyte colony stimulating factor receptor signal transduction, myeloid cell proliferation, and neutrophil activation.
Life sciences 1997;60(9):587-604.
1997: R Möhle; Malcolm A S Moore; RL Nachman; Shahin Rafii
Transendothelial migration of CD34+ and mature hematopoietic cells: an in vitro study using a human bone marrow endothelial cell line.
Blood 1997;89(1):72-80.
1996: F Shapiro; Bronislaw Pytowski; Shahin Rafii; Larry Witte; D J Hicklin; Tzy-Jyun Yao; Malcolm A S Moore
The effects of Flk-2/flt3 ligand as compared with c-kit ligand on short-term and long-term proliferation of CD34+ hematopoietic progenitors elicited from human fetal liver, umbilical cord blood, bone marrow, and mobilized peripheral blood.
Journal of hematotherapy 1996;5(6):655-62.
1996: A Ohwada; Shahin Rafii; Malcolm A S Moore; Helen-Ann Brown Epstein
In vivo adenovirus vector-mediated transfer of the human thrombopoietin cDNA maintains platelet levels during radiation-and chemotherapy-induced bone marrow suppression.
Blood 1996;88(3):778-84.
1996: E Early; Malcolm A S Moore; A Kakizuka; K Nason-Burchenal; P Martin; Ronald M Evans; Ethan Dmitrovsky
Transgenic expression of PML/RARalpha impairs myelopoiesis.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(15):7900-4.
1996: P Szabolcs; D Avigan; S Gezelter; D H Ciocon; Malcolm A S Moore; Ralph M Steinman; James W Young
Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate.
Blood 1996;87(11):4520-30.
1996: Enrique Mesri; Ethel Cesarman; L Arvanitakis; Shahin Rafii; Malcolm A S Moore; David N Posnett; Daniel M Knowles; A S Asch
Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells.
The Journal of experimental medicine 1996;183(5):2385-90.
1996: S V Yurasov; M Flasshove; Shahin Rafii; Malcolm A S Moore
Density enrichment and characterization of hematopoietic progenitors and stem cells from umbilical cord blood.
Bone marrow transplantation 1996;17(4):517-25.
1996: Joan Albanell; W Han; B Mellado; R Gunawardane; Howard I Scher; Ethan Dmitrovsky; Malcolm A S Moore
Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines.
Cancer research 1996;56(7):1503-8.
1996: J Cheng; S Baumhueter; G Cacalano; K Carver-Moore; H Thibodeaux; R Thomas; Hal E Broxmeyer; Scott Cooper; N Hague; Malcolm A S Moore; Laurence A Lasky
Hematopoietic defects in mice lacking the sialomucin CD34.
Blood 1996;87(2):479-90.
1996: Malcolm A S Moore; J P Leonard; M Flasshove; J Bertino; Humilidad F Gallardo; Michel Sadelain
Gene therapy--the challenge for the future.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7 Suppl 2():53-8.
1995: Linda Vahdat; G Raptis; DW Fennelly; N Hamilton; Lilian Reich; A Tiersten; M Harrison; Clifford Hudis; Malcolm A S Moore; Tzy-Jyun Yao
Rapidly cycled courses of high-dose alkylating agents supported by filgrastim and peripheral blood progenitor cells in patients with metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(11):1267-73.
1995: Shahin Rafii; F Shapiro; R Pettengell; B Ferris; R L Nachman; Malcolm A S Moore; A S Asch
Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors.
Blood 1995;86(9):3353-63.
1995: James W Young; P Szabolcs; Malcolm A S Moore
Identification of dendritic cell colony-forming units among normal human CD34+ bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha.
The Journal of experimental medicine 1995;182(4):1111-9.
1995: M Flasshove; Debabrata Banerjee; Joseph R Bertino; Malcolm A S Moore
Increased resistance to methotrexate in human hematopoietic cells after gene transfer of the Ser31 DHFR mutant.
Leukemia 1995;9 Suppl 1():S34-7.
1995: Malcolm A S Moore
Expansion of myeloid stem cells in culture.
Seminars in hematology 1995;32(3):183-200.
1995: P Szabolcs; Malcolm A S Moore; James W Young
Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(11):5851-61.
1995: DW Fennelly; J Schneider; David Spriggs; C Bengala; T Hakes; Lilian Reich; Richard R Barakat; J Curtin; Malcolm A S Moore; William J Hoskins
Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide courses.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(5):1160-6.
1995: M Flasshove; Debabrata Banerjee; Shin Mineishi; M X Li; Joseph R Bertino; Malcolm A S Moore
Ex vivo expansion and selection of human CD34+ peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transfer.
Blood 1995;85(2):566-74.
1995: Malcolm A S Moore
Hematopoietic reconstruction: new approaches.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(1):3-9.
1995: P Szabolcs; E D Feller; Malcolm A S Moore; James W Young
Progenitor recruitment and in vitro expansion of immunostimulatory dendritic cells from human CD34+ bone marrow cells by c-kit-ligand, GM-CSF, and TNF alpha.
Advances in experimental medicine and biology 1995;378():17-20.
1994: Marcus O Muench; Maria-Grazia Roncarolo; R Namikawa; Alicia Bárcena; Malcolm A S Moore
Progress in the ex vivo expansion of hematopoietic progenitors.
Leukemia & lymphoma 1994;16(1-2):1-11.
1994: J G Schneider; John Crown; C Wasserheit; A Kritz; G Wong; Lilian Reich; Larry Norton; Malcolm A S Moore
Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
Bone marrow transplantation 1994;14(6):877-84.
1994: F Shapiro; Tzy-Jyun Yao; G Raptis; Lilian Reich; Larry Norton; Malcolm A S Moore
Optimization of conditions for ex vivo expansion of CD34+ cells from patients with stage IV breast cancer.
Blood 1994;84(10):3567-74.
1994: C Gasparetto; C Smith; AP Gillio; A M Stoppa; Malcolm A S Moore; Richard J O'Reilly
Enrichment of peripheral blood stem cells in a primate model following administration of a single dose of rh-IL-1 beta.
Bone marrow transplantation 1994;14(5):717-23.
1994: Shahin Rafii; F Shapiro; J Rimarachin; R L Nachman; B Ferris; B Weksler; Malcolm A S Moore; A S Asch
Isolation and characterization of human bone marrow microvascular endothelial cells: hematopoietic progenitor cell adhesion.
Blood 1994;84(1):10-9.
1994: Malcolm A S Moore; F Shapiro
Regulation and function of hematopoietic stem cells.
Current opinion in hematology 1994;1(3):180-6.
1994: J H Shieh; R H Peterson; Malcolm A S Moore
Bacterial endotoxin regulation of cytokine receptors on murine bone marrow cells: in vivo and in vitro study.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(2):859-66.
1994: C Gasparetto; C Smith; M Firpo; D Dennig; Trudy N Small; AP Gillio; R Lichtenberg; Richard J O'Reilly; Malcolm A S Moore
Dyshematopoiesis in combined immune deficiency with congenital neutropenia.
American journal of hematology 1994;45(1):63-72.
1994: Malcolm A S Moore; I Hoskins
Ex vivo expansion of cord blood-derived stem cells and progenitors.
Blood cells 1994;20(2-3):468-79; discussion 479-81.
1994: Malcolm A S Moore; J G Schneider; F Shapiro; C Bengala
Ex vivo expansion of CD34+ hematopoietic progenitors.
Progress in clinical and biological research 1994;389():217-28.
1993: AP Gillio; L B Faulkner; BLANCHE ALTER; L Reilly; R Klafter; Glenn Heller; D C Young; Jeffrey Lipton; Malcolm A S Moore; Richard J O'Reilly
Treatment of Diamond-Blackfan anemia with recombinant human interleukin-3.
Blood 1993;82(3):744-51.
1993: AP Gillio; L B Faulkner; BLANCHE ALTER; L Reilly; R Klafter; Glenn Heller; D C Young; Jeffrey Lipton; Malcolm A S Moore; Richard J O'Reilly
Successful treatment of Diamond-Blackfan anemia with interleukin 3.
Stem cells (Dayton, Ohio) 1993;11 Suppl 2():123-30.
1993: Marcus O Muench; M T Firpo; Malcolm A S Moore
Bone marrow transplantation with interleukin-1 plus kit-ligand ex vivo expanded bone marrow accelerates hematopoietic reconstitution in mice without the loss of stem cell lineage and proliferative potential.
Blood 1993;81(12):3463-73.
1993: John Crown; A Kritz; Linda Vahdat; Lilian Reich; Malcolm A S Moore; N Hamilton; J Schneider; M Harrison; Teresa A Gilewski; Clifford Hudis
Rapid administration of multiple cycles of high-dose myelosuppressive chemotherapy in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(6):1144-9.
1993: J H Shieh; R H Peterson; Malcolm A S Moore
Cytokines and dexamethasone modulation of IL-1 receptors on human neutrophils in vitro.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(8 Pt 1):3515-24.
1993: J H Shieh; Michael S Gordon; Ann Jakubowski; R H Peterson; JL Gabrilove; Malcolm A S Moore
Interleukin-1 modulation of cytokine receptors on human neutrophils: in vitro and in vivo studies.
Blood 1993;81(7):1745-54.
1993: C Smith; Marcus O Muench; M Knizewski; Eli Gilboa; Malcolm A S Moore
Development of a lacZ marked WEHI-3B D+ murine leukemic cell line as an in-vivo model of acute non-lymphocytic leukemia.
Leukemia 1993;7(2):310-7.
1993: Malcolm A S Moore
Ex vivo expansion and gene therapy using cord blood CD34+ cells.
Journal of hematotherapy 1993;2(2):221-4.
1992: J Crown; C Wassherheit; T Hakes; DW Fennelly; L Reich; Malcolm A S Moore; J Schneider; J Curtin; S C Rubin; B Reichman
Rapid delivery of multiple high-dose chemotherapy courses with granulocyte colony-stimulating factor and peripheral blood-derived hematopoietic progenitor cells.
Journal of the National Cancer Institute 1992;84(24):1935-6.
1992: Marcus O Muench; Z Guy; Malcolm A S Moore
Ex vivo differentiation therapy as a method of leukemic cell purging in murine bone marrow expansion cultures.
Cancer research 1992;52(23):6576-82.
1992: Marcus O Muench; C Gasparetto; Malcolm A S Moore
The in vitro growth of murine high proliferative potential-colony forming cells is not enhanced by growth in a low oxygen atmosphere.
Cytokine 1992;4(6):488-94.
1992: M Steffen; C Budde-Steffen; JL Gabrilove; Malcolm A S Moore
Modulation of leukemic cell growth by tumor necrosis factor: action and expression in myeloid leukemia.
Leukemia 1992;6(7):634-41.
1992: Malcolm A S Moore
Does stem cell exhaustion result from combining hematopoietic growth factors with chemotherapy? If so, how do we prevent it?
Blood 1992;80(1):3-7.
1992: Marcus O Muench; Malcolm A S Moore
Accelerated recovery of peripheral blood cell counts in mice transplanted with in vitro cytokine-expanded hematopoietic progenitors.
Experimental hematology 1992;20(5):611-8.
1992: Marcus O Muench; J G Schneider; Malcolm A S Moore
Interactions among colony-stimulating factors, IL-1 beta, IL-6, and kit-ligand in the regulation of primitive murine hematopoietic cells.
Experimental hematology 1992;20(3):339-49.
1991: Malcolm A S Moore
The use of colony stimulating factors in combination.
Current opinion in biotechnology 1991;2(6):854-62.
1991: J H Shieh; R H Peterson; Malcolm A S Moore
Granulocyte colony-stimulating factor modulation of cytokine receptors on murine bone marrow cells. In vivo and in vitro studies.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(9):2984-90.
1991: J H Shieh; R H Peterson; Malcolm A S Moore
IL-1 modulation of cytokine receptors on bone marrow cells. In vitro and in vivo studies.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(4):1273-8.
1991: Malcolm A S Moore
Review: Stratton Lecture 1990. Clinical implications of positive and negative hematopoietic stem cell regulators.
Blood 1991;78(1):1-19.
1991: Malcolm A S Moore
The future of cytokine combination therapy.
Cancer 1991;67(10 Suppl):2718-26.
1991: C Smith; C Gasparetto; Nancy Collins; AP Gillio; Marcus O Muench; Richard J O'Reilly; Malcolm A S Moore
Purification and partial characterization of a human hematopoietic precursor population.
Blood 1991;77(10):2122-8.
1991: Malcolm A S Moore; Hugo Castro-Malaspina
Immunosuppression in aplastic anemia--postponing the inevitable?
The New England journal of medicine 1991;324(19):1358-60.
1991: R M Lemoli; C Gasparetto; David A Scheinberg; Malcolm A S Moore; Bayard Clarkson; S C Gulati
Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination.
Blood 1991;77(8):1829-36.
1991: J H Shieh; R H Peterson; Malcolm A S Moore
Modulation of granulocyte colony-stimulating factor receptors on murine peritoneal exudate macrophages by tumor necrosis factor-alpha.
Journal of immunology (Baltimore, Md. : 1950) 1991;146(8):2648-53.
1991: Malcolm A S Moore
The clinical use of colony stimulating factors.
Annual review of immunology 1991;9():159-91.
1990: D J Warren; L Slørdal; Malcolm A S Moore
Tumor-necrosis factor induces cell cycle arrest in multipotential hematopoietic stem cells: a possible radioprotective mechanism.
European journal of haematology 1990;45(3):158-63.
1990: L Slørdal; D J Warren; Malcolm A S Moore
Protective effects of tumor necrosis factor on murine hematopoiesis during cycle-specific cytotoxic chemotherapy.
Cancer research 1990;50(14):4216-20.
1990: Malcolm A S Moore; R L Stolfi; Daniel S Martin
Hematologic effects of interleukin-1 beta, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor in tumor-bearing mice treated with fluorouracil.
Journal of the National Cancer Institute 1990;82(12):1031-7.
1990: Joseph H Laver; E Duncan; Miguel R Abboud; C Gasparetto; I Sahdev; D Warren; J Bussel; P Auld; Richard J O'Reilly; Malcolm A S Moore
High levels of granulocyte and granulocyte-macrophage colony-stimulating factors in cord blood of normal full-term neonates.
The Journal of pediatrics 1990;116(4):627-32.
1990: Malcolm A S Moore
Hematopoietic growth factors in cancer.
Cancer 1990;65(3 Suppl):836-44.
1990: Malcolm A S Moore
Haemopoietic growth factor interactions: in vitro and in vivo preclinical evaluation.
Cancer surveys 1990;9(1):7-80.
1990: Malcolm A S Moore; Marcus O Muench; D J Warren; J Laver
Cytokine networks involved in the regulation of haemopoietic stem cell proliferation and differentiation.
Ciba Foundation symposium 1990;148():43-58; discussion 58-61.
1989: L Slørdal; Marcus O Muench; D J Warren; Malcolm A S Moore
Radioprotection by murine and human tumor-necrosis factor: dose-dependent effects on hematopoiesis in the mouse.
European journal of haematology 1989;43(5):428-34.
1989: W L McGuire; J Gabrilove; Malcolm A S Moore; J Rinehart
Colony-stimulating factors. A panel discussion.
Breast cancer research and treatment 1989;14(2):193-200.
1989: J H Shieh; R H Peterson; D J Warren; Malcolm A S Moore
Modulation of colony-stimulating factor-1 receptors on macrophages by tumor necrosis factor.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(8):2534-9.
1989: Joseph H Laver; Malcolm A S Moore
Clinical use of recombinant human hematopoietic growth factors.
Journal of the National Cancer Institute 1989;81(18):1370-82.
1989: C Gasparetto; Joseph H Laver; Miguel R Abboud; AP Gillio; C Smith; Richard J O'Reilly; Malcolm A S Moore
Effects of interleukin-1 on hematopoietic progenitors: evidence of stimulatory and inhibitory activities in a primate model.
Blood 1989;74(2):547-50.
1989: M Steffen; M Abboud; G K Potter; Y P Yung; Malcolm A S Moore
Presence of tumour necrosis factor or a related factor in human basophil/mast cells.
Immunology 1989;66(3):445-50.
1989: L Slørdal; D J Warren; Malcolm A S Moore
Effect of recombinant murine tumor necrosis factor on hemopoietic reconstitution in sublethally irradiated mice.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(3):833-5.
1989: Ann Jakubowski; L Souza; F Kelly; K Fain; D Budman; Bayard Clarkson; M A Bonilla; Malcolm A S Moore; JL Gabrilove
Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia.
The New England journal of medicine 1989;320(1):38-42.
1989: Malcolm A S Moore
Interactions between hematopoietic growth factors in normal and leukemic stem cell differentiation.
Annals of the New York Academy of Sciences 1989;567():171-81.
1989: Joseph H Laver; Miguel R Abboud; C Gasparetto; AP Gillio; C Smith; Richard J O'Reilly; Malcolm A S Moore
Effects of IL-1 on hematopoietic progenitors after myelosuppressive chemoradiotherapy.
Biotherapy (Dordrecht, Netherlands) 1989;1(4):293-300.
1989: Malcolm A S Moore
Interactions between hematopoietic growth factors: the clinical role of combination biotherapy.
Haematology and blood transfusion 1989;32():11-21.
1989: Malcolm A S Moore
Role of interleukin-1 in hematopoiesis.
Immunologic research 1989;8(3):165-75.
1988: Sheng-Yuan Wang; C K Ho; L Y Chen; R C Wang; M H Huang; Hugo Castro-Malaspina; Malcolm A S Moore
Down regulation of myelopoiesis by mediators inhibiting the production of macrophage-derived granulomonopoietic enhancing activity (GM-EA).
Blood 1988;72(6):2001-6.
1988: O G Ottmann; K H Nocka; Malcolm A S Moore; L M Pelus
Differential expression of class II MHC antigens in subpopulations of human hematopoietic progenitor cells.
Leukemia 1988;2(10):677-86.
1988: C D Lothrop; D J Warren; L M Souza; J B Jones; Malcolm A S Moore
Correction of canine cyclic hematopoiesis with recombinant human granulocyte colony-stimulating factor.
Blood 1988;72(4):1324-8.
1988: Joseph H Laver; Hugo Castro-Malaspina; Nancy A Kernan; J Levick; R L Evans; Richard J O'Reilly; Malcolm A S Moore
In vitro interferon-gamma production by cultured T-cells in severe aplastic anaemia: correlation with granulomonopoietic inhibition in patients who respond to anti-thymocyte globulin.
British journal of haematology 1988;69(4):545-50.
1988: JL Gabrilove; Ann Jakubowski; Howard I Scher; C Sternberg; G Wong; J Grous; A Yagoda; K Fain; Malcolm A S Moore; Bayard Clarkson
Recombinant human granulocyte colony stimulating factors: therapeutic application in the prevention of chemotherapy-induced neutropenia.
Behring Institute Mitteilungen 1988;(83):229-33.
1988: JL Gabrilove; Ann Jakubowski; Howard I Scher; C Sternberg; G Wong; J Grous; A Yagoda; K Fain; Malcolm A S Moore; Bayard Clarkson
Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium.
The New England journal of medicine 1988;318(22):1414-22.
1988: M Steffen; O G Ottmann; Malcolm A S Moore
Simultaneous production of tumor necrosis factor-alpha and lymphotoxin by normal T cells after induction with IL-2 and anti-T3.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(8):2621-4.
1988: M Steffen; Y Cayre; K R Manogue; Malcolm A S Moore
1,25-Dihydroxyvitamin D3 transcriptionally regulates tumour necrosis factor mRNA during HL-60 cell differentiation.
Immunology 1988;63(1):43-6.
1988: J Steinberg; C Bona; A Polyzos; Malcolm A S Moore; Chris D Platsoucas
Proliferation of leukemic B cells in response to SAC and anti-mu. Evidence for different modes of action and comparison to proliferation and differentiation induced by conditioned medium.
Leukemia research 1988;12(7):559-66.
1988: D J Warren; Malcolm A S Moore
Synergism among interleukin 1, interleukin 3, and interleukin 5 in the production of eosinophils from primitive hemopoietic stem cells.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(1):94-9.
1988: Malcolm A S Moore
The use of hematopoietic growth and differentiation factors for bone marrow stimulation.
Important advances in oncology 1988;():31-54.
1987: Malcolm A S Moore; D J Warren
Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(20):7134-8.
1987: J Steinberg; Malcolm A S Moore; C A Bona; W R Benjamin; J J Farrar; P C Familletti; C D Platsoucas
Inhibition of spontaneous proliferation of human leukemic B cells from patients with chronic lymphocytic leukemia by anti-mu antibodies.
Clinical immunology and immunopathology 1987;44(3):371-80.
1987: L Lu; L M Pelus; W Piacibello; Malcolm A S Moore; W Hu; H E Broxmeyer
Prostaglandin E acts at two levels to enhance colony formation in vitro by erythroid (BFU-E) progenitor cells.
Experimental hematology 1987;15(7):765-71.
1987: J F Moreau; M Bonneville; Anne Godard; Hugues Gascan; V Gruart; Malcolm A S Moore; J P Soulillou
Characterization of a factor produced by human T cell clones exhibiting eosinophil-activating and burst-promoting activities.
Journal of immunology (Baltimore, Md. : 1950) 1987;138(11):3844-9.
1987: J Steinberg; Malcolm A S Moore; B Bernhardt; C A Bona; C D Platsoucas
Induction of proliferation and differentiation of leukaemic B cells from patients with chronic lymphocytic leukaemia by anti-mu and conditioned medium.
Scandinavian journal of immunology 1987;25(6):599-611.
1987: Karl Welte; M A Bonilla; AP Gillio; Tom Boone; G K Potter; JL Gabrilove; Malcolm A S Moore; Richard J O'Reilly; L M Souza
Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates.
The Journal of experimental medicine 1987;165(4):941-8.
1987: Karl Welte; M A Bonilla; JL Gabrilove; AP Gillio; G K Potter; Malcolm A S Moore; Richard J O'Reilly; Tom Boone; L M Souza
Recombinant human granulocyte-colony stimulating factor: in vitro and in vivo effects on myelopoiesis.
Blood cells 1987;13(1-2):17-30.
1987: O G Ottmann; Karl Welte; L M Souza; Malcolm A S Moore
Proliferative effects of a recombinant human granulocyte colony-stimulating factor (rG-CSF) on highly enriched hematopoietic progenitor cells.
Haematology and blood transfusion 1987;31():244-7.
1987: Malcolm A S Moore; Karl Welte; JL Gabrilove; L M Souza
Biological activities of recombinant human granulocyte colony stimulating factor (rhG-CSF) and tumor necrosis factor: in vivo and in vitro analysis.
Haematology and blood transfusion 1987;31():210-20.
1986: Dagfinn Løvhaug; Louis M Pelus; E M Nordlie; A Bøyum; Malcolm A S Moore
Monocyte-conditioned medium and interleukin 1 induce granulocyte-macrophage colony-stimulating factor production in the adherent cell layer of murine bone marrow cultures.
Experimental hematology 1986;14(11):1037-42.
1986: E Platzer; S Oez; Karl Welte; A Sendler; J L Gabrilove; R Mertelsmann; Malcolm A S Moore; Joachim R Kalden
Human pluripotent hemopoietic colony stimulating factor: activities on human and murine cells.
Immunobiology 1986;172(3-5):185-93.
1986: Malcolm A S Moore; T Nakamura; N Ito
Immunohistochemically demonstrated glucose-6-phosphate dehydrogenase, gamma-glutamyl transpeptidase, ornithine decarboxylase and glutathione S-transferase enzymes: absence of direct correlation with cell proliferation in rat liver putative pre-neoplastic lesions.
Carcinogenesis 1986;7(9):1419-24.
1986: L Lu; L M Pelus; H E Broxmeyer; Malcolm A S Moore; M Wachter; D Walker; E Platzer
Enhancement of the proliferation of human marrow erythroid (BFU-E) progenitor cells by prostaglandin E requires the participation of OKT8-positive T lymphocytes and is associated with the density expression of major histocompatibility complex class II antigens on BFU-E.
Blood 1986;68(1):126-33.
1986: J L Gabrilove; Karl Welte; P Harris; E Platzer; L Lu; E Levi; R Mertelsmann; Malcolm A S Moore
Pluripoietin alpha: a second human hematopoietic colony-stimulating factor produced by the human bladder carcinoma cell line 5637.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(8):2478-82.
1986: T M Dexter; Malcolm A S Moore
Growth and development in the haemopoietic system: the role of lymphokines and their possible therapeutic potential in disease and malignancy.
Carcinogenesis 1986;7(4):509-16.
1986: Malcolm A S Moore
Biologicals for cancer treatment: growth and differentiating agents.
Hospital practice (Office ed.) 1986;21(2):69-80.
1985: E Platzer; Karl Welte; J L Gabrilove; L Lu; P Harris; R Mertelsmann; Malcolm A S Moore
Biological activities of a human pluripotent hemopoietic colony stimulating factor on normal and leukemic cells.
The Journal of experimental medicine 1985;162(6):1788-801.
1985: V J Merluzzi; D M Savage; M D Smith; K Last-Barney; Roland Mertelsmann; Malcolm A S Moore; K Welte
Lymphokine-activated killer cells are generated before classical cytotoxic T lymphocytes after bone marrow transplantation in mice.
Journal of immunology (Baltimore, Md. : 1950) 1985;135(3):1702-6.
1985: G K Potter; Anwar N Mohamed; N C Dracopoli; S L Groshen; R N Shen; Malcolm A S Moore
Action of 1,25-(OH)2D3 in nude mice bearing transplantable human myelogenous leukemic cell lines.
Experimental hematology 1985;13(8):722-32.
1985: S Y Wang; Hugo Castro-Malaspina; Malcolm A S Moore
Long-term culture of human bone marrow macrophages: macrophage development is associated with the production of granulomonopoietic enhancing activity (GM-EA).
Journal of immunology (Baltimore, Md. : 1950) 1985;135(2):1186-93.
1985: J L Gabrilove; K Welte; L Lu; Hugo Castro-Malaspina; Malcolm A S Moore
Constitutive production of leukemia differentiation, colony-stimulating, erythroid burst-promoting, and pluripoietic factors by a human hepatoma cell line: characterization of the leukemia differentiation factor.
Blood 1985;66(2):407-15.
1985: P E Harris; P Ralph; J Gabrilove; K Welte; R Karmali; Malcolm A S Moore
Distinct differentiation-inducing activities of gamma-interferon and cytokine factors acting on the human promyelocytic leukemia cell line HL-60.
Cancer research 1985;45(7):3090-5.
1985: W Ebell; Hugo Castro-Malaspina; Malcolm A S Moore; Richard J O'Reilly
Depletion of stromal cell elements in human marrow grafts separated by soybean agglutinin.
Blood 1985;65(5):1105-11.
1985: S Y Wang; Hugo Castro-Malaspina; L Lu; Malcolm A S Moore
Biological characterization of a granulomonopoietic enhancing activity derived from cultured human lipid-containing macrophages.
Blood 1985;65(5):1181-90.
1985: Z A Arlin; R Mertelsmann; Ellin Berman; T Gee; E Kurland; Raju S K Chaganti; Suresh C Jhanwar; Malcolm A S Moore; Bayard Clarkson
13-cis-Retinoic acid does not increase the true remission rate and the duration of true remission (induced by cytotoxic chemotherapy) in patients with chronic phase chronic myelogenous leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(4):473-6.
1985: S Siena; Hugo Castro-Malaspina; S C Gulati; L Lu; M O Colvin; Bayard Clarkson; Richard J O'Reilly; Malcolm A S Moore
Effects of in vitro purging with 4-hydroperoxycyclophosphamide on the hematopoietic and microenvironmental elements of human bone marrow.
Blood 1985;65(3):655-62.
1985: Y P Yung; K Okumura; Malcolm A S Moore
Generation of natural killer cell lines from murine long-term bone marrow cultures.
Journal of immunology (Baltimore, Md. : 1950) 1985;134(3):1462-8.
1985: Karl Welte; E Platzer; L Lu; J L Gabrilove; E Levi; R Mertelsmann; Malcolm A S Moore
Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(5):1526-30.
1985: Y P Yung; Malcolm A S Moore
Mast-cell growth factor: its role in mast-cell differentiation, proliferation, and maturation.
Contemporary topics in molecular immunology 1985;10():147-79.
1985: E Platzer; B Y Rubin; L Lu; K Welte; H E Broxmeyer; Malcolm A S Moore
OKT3 monoclonal antibody induces production of colony-stimulating factor(s) for granulocytes and macrophages in cultures of human T lymphocytes and adherent cells.
Journal of immunology (Baltimore, Md. : 1950) 1985;134(1):265-71.
1985: E Platzer; Karl Welte; L Lu; J L Gabrilove; Y P Yung; C F Nathan; R Mertelsmann; Malcolm A S Moore
Biological activities of a human pluripotent hemopoietic colony-stimulating factor.
Haematology and blood transfusion 1985;29():418-22.
1985: Karl Welte; E Platzer; J L Gabrilove; L Lu; E Levi; A Polivka; R Mertelsmann; Malcolm A S Moore
Purification to apparent homogeneity and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor.
Haematology and blood transfusion 1985;29():398-401.
1985: L Lu; H E Broxmeyer; Malcolm A S Moore; A P Sheridan; P Gentile
Abnormalities in myelopoietic regulatory interactions with acidic isoferritins and lactoferrin in mice infected with Friend virus complex: association with altered expression of Ia antigens on effector and responding cells.
Blood 1985;65(1):91-9.
1984: K Welte; M Andreeff; E Platzer; K Holloway; B Y Rubin; Malcolm A S Moore; R Mertelsmann
Interleukin 2 regulates the expression of Tac antigen on peripheral blood T lymphocytes.
The Journal of experimental medicine 1984;160(5):1390-403.
1984: R Mertelsmann; K Welte; C Sternberg; Richard J O'Reilly; Malcolm A S Moore; Bayard Clarkson; H F Oettgen
Treatment of immunodeficiency with interleukin-2: initial exploration.
Journal of biological response modifiers 1984;3(5):483-90.
1984: K Welte; N Ciobanu; Malcolm A S Moore; S Gulati; Richard J O'Reilly; R Mertelsmann
Defective interleukin 2 production in patients after bone marrow transplantation and in vitro restoration of defective T lymphocyte proliferation by highly purified interleukin 2.
Blood 1984;64(2):380-5.
1984: G Kruger; K Welte; N Ciobanu; Charlotte Cunningham-Rundles; P Ralph; S Venuta; S Feldman; B Koziner; C Y Wang; Malcolm A S Moore
Interleukin-2 correction of defective in vitro T-cell mitogenesis in patients with common varied immunodeficiency.
Journal of clinical immunology 1984;4(4):295-303.
1984: P Ralph; K Welte; E Levi; I Nakoinz; P B Litcofsky; R H Mertelsmann; Malcolm A S Moore
Human B cell-inducing factor(s) for production of IgM, IgG and IgA: independence from IL 2.
Journal of immunology (Baltimore, Md. : 1950) 1984;132(4):1858-62.
1984: Malcolm A S Moore; J Gabrilove; L Lu; Y P Yung
Myeloid and erythroid stem cells: regulation in normal and neoplastic states.
Symposium on Fundamental Cancer Research 1984;37():147-58.
1983: P Ralph; P E Harris; C J Punjabi; K Welte; P B Litcofsky; M K Ho; B Y Rubin; Malcolm A S Moore; T A Springer
Lymphokine inducing "terminal differentiation" of the human monoblast leukemia line U937: a role for gamma interferon.
Blood 1983;62(6):1169-75.
1983: K Welte; E Platzer; C Y Wang; E A Rinnooy Kan; Malcolm A S Moore; R Mertelsmann
OKT8 antibody inhibits OKT3-induced IL 2 production and proliferation in OKT8+ cells.
Journal of immunology (Baltimore, Md. : 1950) 1983;131(5):2356-61.
1983: E J Gold; R H Mertelsmann; L M Itri; T Gee; Z Arlin; Sanford J. Kempin; Bayard Clarkson; Malcolm A S Moore
Phase I clinical trial of 13-cis-retinoic acid in myelodysplastic syndromes.
Cancer treatment reports 1983;67(11):981-6.
1983: N Ciobanu; K Welte; G Kruger; S Venuta; J Gold; S P Feldman; C Y Wang; B Koziner; Malcolm A S Moore; B Safai
Defective T-cell response to PHA and mitogenic monoclonal antibodies in male homosexuals with acquired immunodeficiency syndrome and its in vitro correction by interleukin 2.
Journal of clinical immunology 1983;3(4):332-40.
1983: E J Gold; M Conjalka; L M Pelus; Suresh C Jhanwar; H Broxmeyer; A B Middleton; Bayard Clarkson; Malcolm A S Moore
Marrow cytogenetic and cell-culture analyses of the myelodysplastic syndromes: insights to pathophysiology and prognosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1983;1(10):627-34.
1983: D H Maurer; K Welte; R Mertelsmann; Malcolm A S Moore; P Ralph
Lymphokine factors inducing IgG production in human B-cell line ARH-77 and stimulatory effects of phorbol ester tumor promoter.
Cellular immunology 1983;79(1):36-43.
1983: Y P Yung; S Y Wang; Malcolm A S Moore
Characterization of mast cell precursors by physical means: dissociation from T cells and T cell precursors.
Journal of immunology (Baltimore, Md. : 1950) 1983;130(6):2843-8.
1983: C J Punjabi; Malcolm A S Moore; P Ralph
Suppression of natural killer activity in human blood and bone marrow cultures by bone marrow-adherent OKM1-positive cells.
Cellular immunology 1983;77(1):13-22.
1983: S P Feldman; R Mertelsmann; S Venuta; M Andreeff; K Welte; Malcolm A S Moore
Sodium azide enhancement of interleukin-2 production.
Blood 1983;61(4):815-8.
1983: S Venuta; R Mertelsmann; K Welte; S P Feldman; C Y Wang; Malcolm A S Moore
Production and regulation of interleukin-2 in human lymphoblastic leukemias studied with T-cell monoclonal antibodies.
Blood 1983;61(4):781-9.
1983: L Lu; H E Broxmeyer; Paul A Meyers; Malcolm A S Moore; Howard T Thaler
Association of cell cycle expression of Ia-like antigenic determinations on normal human multipotential (CFU-GEMM) and erythroid (BFU-E) progenitor cells with regulation in vitro by acidic isoferritins.
Blood 1983;61(2):250-6.
1983: K Welte; S Venuta; C Y Wang; S P Feldman; N Ciobanu; G Kruger; H J Feickert; V J Merluzzi; N Flomenberg; Malcolm A S Moore; R Mertelsmann
Human interleukin 2: physiology, biochemistry, and pathophysiology in lymphoblastic leukemias and immunodeficiency syndromes.
Haematology and blood transfusion 1983;28():369-79.
1983: Malcolm A S Moore; J Gabrilove; A P Sheridan
Therapeutic implications of serum factors inhibiting proliferation and inducing differentiation of myeloid leukemic cells.
Blood cells 1983;9(1):125-44.
1983: Malcolm A S Moore; J Gabrilove; A P Sheridan
Myeloid leukemic cell differentiation induced by human postendotoxin serum and vitamin analogues.
Haematology and blood transfusion 1983;28():327-37.
1983: Y P Yung; Malcolm A S Moore
Mast cell growth factor.
Lymphokine research 1983;2(4):127-31.
1982: Y P Yung; Malcolm A S Moore
Long-term in vitro culture of murine mast cells. III. Discrimination of mast cells growth factor and granulocyte-CSF.
Journal of immunology (Baltimore, Md. : 1950) 1982;129(3):1256-61.
1982: K Welte; C Y Wang; R Mertelsmann; S Venuta; S P Feldman; Malcolm A S Moore
Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity.
The Journal of experimental medicine 1982;156(2):454-64.
1982: P Ralph; N Williams; Malcolm A S Moore; P B Litcofsky
Induction of antibody-dependent and nonspecific tumor killing in human monocytic leukemia cells by nonlymphocyte factors and phorbol ester.
Cellular immunology 1982;71(2):215-23.
1982: Hugo Castro-Malaspina; R E Gay; Suresh C Jhanwar; J A Hamilton; D R Chiarieri; Paul A Meyers; S Gay; Malcolm A S Moore
Characteristics of bone marrow fibroblast colony-forming cells (CFU-F) and their progeny in patients with myeloproliferative disorders.
Blood 1982;59(5):1046-54.
1982: L M Pelus; S Saletan; R T Silver; Malcolm A S Moore
Expression of Ia-antigens on normal and chronic myeloid leukemic human granulocyte-macrophage colony-forming cells (CFU-GM) is associated with the regulation of cell proliferation by prostaglandin E.
Blood 1982;59(2):284-92.
1982: C D Dunn; J B Jones; R D Lange; E G Wright; Malcolm A S Moore
Production of presumptive humoral haematopoietic regulators in canine cyclic haematopoiesis.
Cell and tissue kinetics 1982;15(1):1-10.
1982: G Steinmann; H E Broxmeyer; E de Harven; Malcolm A S Moore
Immuno-electron microscopic tracing of lactoferrin, a regulator of myelopoiesis, into a subpopulation of human peripheral blood monocytes.
British journal of haematology 1982;50(1):75-84.
1982: R Mertelsmann; Malcolm A S Moore; Bayard Clarkson
Leukemia cell phenotype and prognosis: an analysis of 519 adults with acute leukemia.
Blood cells 1982;8(3):561-83.
1982: Malcolm A S Moore
G-CSF: its relationship to leukemia differentiation-inducing activity and other hemopoietic regulators.
Journal of cellular physiology. Supplement 1982;1():53-64.
1982: Hugo Castro-Malaspina; Malcolm A S Moore
Pathophysiological mechanisms operating in the development of myelofibrosis: role of megakaryocytes.
Nouvelle revue française d'hématologie 1982;24(4):221-6.
1981: S Gillis; R Mertelsmann; Malcolm A S Moore
T-cell growth factor (interleukin 2) control of T-lymphocyte proliferation: possible involvement in leukemogenesis.
Transplantation proceedings 1981;13(4):1884-90.
1981: R Mertelsmann; Malcolm A S Moore; H E Broxmeyer; C Cirrincione; Bayard Clarkson
Diagnostic and prognostic significance of the CFU-c assay in acute nonlymphoblastic leukemia.
Cancer research 1981;41(11 Pt 2):4844-8.
1981: L Lu; H E Broxmeyer; L M Pelus; M Andreeff; Malcolm A S Moore
Detection of luxol-fast-blue positive cells in human promyelocytic leukemia cell line HL-60.
Experimental hematology 1981;9(9):887-92.
1981: L M Pelus; H E Broxmeyer; Malcolm A S Moore
Regulation of human myelopoiesis by prostaglandin E and lactoferrin.
Cell and tissue kinetics 1981;14(5):515-26.
1981: G Tertian; Y P Yung; D Guy-Grand; Malcolm A S Moore
Long-term in vitro culture of murine mast cells. I. Description of a growth factor-dependent culture technique.
Journal of immunology (Baltimore, Md. : 1950) 1981;127(2):788-94.
1981: R Mertelsmann; S Gillis; G Steinmann; P Ralph; M Stiehm; B Koziner; Malcolm A S Moore
T-cell growth factor (interleukin 2) and terminal transferase activity in human leukemias and lymphoblastic cell lines.
Blut 1981;43(2):99-103.
1981: Y P Yung; R Eger; G Tertian; Malcolm A S Moore
Long-term in vitro culture of murine mast cells. II. Purification of a mast cell growth factor and its dissociation from TCGF.
Journal of immunology (Baltimore, Md. : 1950) 1981;127(2):794-9.
1981: Robert Stuart; J A Hamilton; L L Sensenbrenner; Malcolm A S Moore
Regulation of myelopoiesis in vitro: partial replacement of colony-stimulating factors by tumor-promoting phorbol esters.
Blood 1981;57(6):1032-42.
1981: Hugo Castro-Malaspina; E M Rabellino; A Yen; R L Nachman; Malcolm A S Moore
Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts.
Blood 1981;57(4):781-7.
1981: L M Pelus; H E Broxmeyer; M DeSousa; Malcolm A S Moore
Heterogeneity among resident murine peritoneal macrophages: separation and functional characterization of monocytoid cells producing granulocyte-macrophage colony-stimulating factor (GM-CSF) and responding to regulation by lactoferrin.
Journal of immunology (Baltimore, Md. : 1950) 1981;126(3):1016-21.
1981: G Steinmann; R Mertelsmann; E deHarven; Malcolm A S Moore
Ultrastructural demonstration of terminal deoxynucleotidyl transferase (TdT).
Blood 1981;57(2):368-71.
1981: Malcolm A S Moore
Genetic and oncogenic influences on myelopoiesis.
Haematology and blood transfusion 1981;26():237-42.
1981: R Mertelsmann; Malcolm A S Moore; Bayard Clarkson
Methods and clinical relevance of terminal deoxynucleotidyl transferase determination in leukemic cells.
Haematology and blood transfusion 1981;26():68-72.
1981: Malcolm A S Moore; R Mertelsmann; L M Pelus
Phenotypic evaluation of chronic myeloid leukemia.
Blood cells 1981;7(2):217-36.
1980: G Tertian; M Dy; Y P Yung; D Guy-Grand; Malcolm A S Moore; J Hamburger
[Production of a mastocyte growth factor in lymphocyte cultures stimulated by a mitogen or by allogenic cells].
Comptes rendus des séances de l'Académie des sciences. Série D, Sciences naturelles 1980;291(13):1041-6.
1980: David J Straus; R Mertelsmann; B Koziner; S McKenzie; E de Harven; Z A Arlin; Sanford J. Kempin; H Broxmeyer; Malcolm A S Moore; C J Menendez-Botet; T S Gee; Bayard Clarkson
The acute monocytic leukemias: multidisciplinary studies in 45 patients.
Medicine 1980;59(6):409-25.
1980: S C Gulati; R Mertelsmann; T Gee; R A Good; Bayard Clarkson; Malcolm A S Moore; B Koziner
Analysis of multiple cell markers in acute leukemia complicating Hodgkin's disease.
Cancer 1980;46(4):725-9.
1980: Hugo Castro-Malaspina; R E Gay; G Resnick; N Kapoor; Paul A Meyers; D Chiarieri; S McKenzie; H E Broxmeyer; Malcolm A S Moore
Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny.
Blood 1980;56(2):289-301.
1980: L M Pelus; H E Broxmeyer; Bayard Clarkson; Malcolm A S Moore
Abnormal responsiveness of granulocyte-macrophage committed colony-forming cells from patients with chronic myeloid leukemia to inhibition by prostaglandin E1.
Cancer research 1980;40(7):2512-5.
1980: M Ito; P Ralph; Malcolm A S Moore
Suppression of spleen natural killing activity induced by BCG.
Clinical immunology and immunopathology 1980;16(1):30-8.
1980: J I Kurland; Paul A Meyers; Malcolm A S Moore
Synthesis and release of erythroid colony- and burst-potentiating activities by purified populations of murine peritoneal macrophages.
The Journal of experimental medicine 1980;151(4):839-52.
1980: Malcolm A S Moore; H E Broxmeyer; A P Sheridan; Paul A Meyers; N Jacobsen; R J Winchester
Continuous human bone marrow culture: Ia antigen characterization of probable pluripotential stem cells.
Blood 1980;55(4):682-90.
1980: N Jacobsen; H E Broxmeyer; R J Winchester; Malcolm A S Moore
Expression of DR antigens on early human progenitors of neutrophilic and eosinophilic colonies in diffusion chambers (CFUd).
Scandinavian journal of haematology 1980;24(3):227-33.
1980: E G Wright; P Sheridan; Malcolm A S Moore
An inhibitor of murine stem cell proliferation produced by normal human bone marrow.
Leukemia research 1980;4(3):309-14.
1980: M J Modak; R Mertelsmann; B Koziner; Rajendra Pahwa; Malcolm A S Moore; Bayard Clarkson; R A Good
A micromethod for determination of terminal deoxynucleotidyl transferase (TdT) in the diagnostic evaluation of acute leukemias.
Journal of cancer research and clinical oncology 1980;98(1):91-104.
1980: G Tertian; Y P Yung; Malcolm A S Moore
Induction and long-term maintenance of Thy-1 positive T lymphocytes: derivation from continuous bone marrow cultures.
Journal of supramolecular structure 1980;13(4):533-9.
1979: Malcolm A S Moore; A P Sheridan; Terence Allen; T M Dexter
Prolonged hematopoiesis in a primate bone marrow culture system: characteristics of stem cell production and the hematopoietic microenvironment.
Blood 1979;54(4):775-93.
1979: C J Paige; P W Kincade; Malcolm A S Moore; G Lee
The fate of fetal and adult B-cell progenitors grafted into immunodeficient CBA/N mice.
The Journal of experimental medicine 1979;150(3):548-63.
1979: H E Broxmeyer; E Grossbard; N Jacobsen; Malcolm A S Moore
Persistence of inhibitory activity against normal bone-marrow cells during remission of acute leukemia.
The New England journal of medicine 1979;301(7):346-51.
1979: M Ito; P Ralph; Malcolm A S Moore
In vitro stimulation of phagocytosis in a macrophage cell line measured by a convenient radiolabeled latex bead assay.
Cellular immunology 1979;46(1):48-56.
1979: L M Pelus; H E Broxmeyer; J I Kurland; Malcolm A S Moore
Regulation of macrophage and granulocyte proliferation. Specificities of prostaglandin E and lactoferrin.
The Journal of experimental medicine 1979;150(2):277-92.
1979: P W Kincade; G Lee; Gabriel Fernandes; Malcolm A S Moore; N Williams; R A Good
Abnormalities in clonable B lymphocytes and myeloid progenitors in autoimmune NZB mice.
Proceedings of the National Academy of Sciences of the United States of America 1979;76(7):3464-8.
1979: Malcolm A S Moore; A P Sheridan
Pluripotential stem cell replication in continuous human, prosimian, and murine bone marrow culture.
Blood cells 1979;5(2):297-311.
1979: Malcolm A S Moore
Humoral regulation of granulopoiesis.
Clinics in haematology 1979;8(2):287-309.
1979: J I Kurland; L M Pelus; P Ralph; R S Bockman; Malcolm A S Moore
Induction of prostaglandin E synthesis in normal and neoplastic macrophages: role for colony-stimulating factor(s) distinct from effects on myeloid progenitor cell proliferation.
Proceedings of the National Academy of Sciences of the United States of America 1979;76(5):2326-30.
1979: N Jacobsen; H E Broxmeyer; E Grossbard; Malcolm A S Moore
Colony-forming units in diffusion chambers (CFU-d) and colony-forming units in agar culture (CFU-c) obtained from normal human bone marrow: a possible parent-progeny relationship.
Cell and tissue kinetics 1979;12(2):213-26.
1979: H E Broxmeyer; P Ralph; V B Margolis; I Nakoinz; Paul A Meyers; N Kapoor; Malcolm A S Moore
Characteristics of bone marrow and blood cells in human leukemia that produce leukemia inhibitory activity (LIA).
Leukemia research 1979;3(4):193-203.
1979: R Mertelsmann; B Koziner; D A Filippa; E Grossbard; G Incefy; Malcolm A S Moore; Bayard Clarkson
Clinical significance of TdT, cell surface markers and CFU-C in 297 patients with hematopoietic neoplasias.
Haematology and blood transfusion 1979;23():131-8.
1979: R Mertelsmann; D A Filippa; B Koziner; E Grossbard; J Beck; Malcolm A S Moore; P H Lieberman; Bayard Clarkson; S Gupta; R A Good
Correlation of biochemical and immunological markers with conventional morphology and clinical features in 120 patients with malignant lymphomas.
Advances in experimental medicine and biology 1979;114():553-60.
1979: Malcolm A S Moore
Regulatory interactions in normal and leukemic myelopoiesis.
Haematology and blood transfusion 1979;23():171-80.
1979: Malcolm A S Moore
Interpretations of culture data in aplastic anemia: evidence for a suppressor cell involvement.
Haematology and blood transfusion 1979;24():265-71.
1978: H E Broxmeyer; Malcolm A S Moore
Communication between white cells and the abnormalities of this in leukemia.
Biochimica et biophysica acta 1978;516(2):129-66.
1978: P W Kincade; Malcolm A S Moore; G Lee; C J Paige
Colony-forming B cells in F1 hybrid and transplanted CBA/N mice.
Cellular immunology 1978;40(2):294-302.
1978: J A Hamilton; P Ralph; Malcolm A S Moore
A macrophage tumor cell line and plasminogen activator. A potential model system for macrophage regulation of enzyme production.
The Journal of experimental medicine 1978;148(3):811-6.
1978: R Mertelsmann; B Koziner; Malcolm A S Moore
TdT activity in B cell ALL.
Blood 1978;52(3):638-9.
1978: R J Winchester; Paul A Meyers; H E Broxmeyer; C Y Wang; Malcolm A S Moore; H G Kunkel
Inhibition of human erythropoietic colony formation in culture by treatment with Ia antisera.
The Journal of experimental medicine 1978;148(2):613-8.
1978: J I Kurland; H E Broxmeyer; L M Pelus; R S Bockman; Malcolm A S Moore
Role for monocyte-macrophage-derived colony-stimulating factor and prostaglandin E in the positive and negative feedback control of myeloid stem cell proliferation.
Blood 1978;52(2):388-407.
1978: N Williams; R R Eger; Malcolm A S Moore; N Mendelsohn
Differentiation of mouse bone marrow precursor cells into neutrophil granulocytes by an activity separation from WEHI-3 cell-conditioned medium.
Differentiation; research in biological diversity 1978;11(1):59-63.
1978: L Delmonte; N Williams; Malcolm A S Moore
Effect of myleran on murine hemopoiesis. III. Changes in the density distribution of spleen colony forming (CFU-S) and agar gel colony forming cells (CFU-C).
Cell and tissue kinetics 1978;11(4):369-75.
1978: N Jacobsen; H E Broxmeyer; E Grossbard; Malcolm A S Moore
Diversity of human granulopoietic precursor cells: separation of cells that form colonies in diffusion chambers (CFU-d) from populations of colony-forming cells in vitro (CFU-c) by velocity sedimentation.
Blood 1978;52(1):221-32.
1978: R Mertelsmann; B Koziner; R Ralph; D Filippa; S McKenzie; Z A Arlin; T S Gee; Malcolm A S Moore; Bayard Clarkson
Evidence for distinct lymphocytic and monocytic populations in a patient with terminal transferase--positive acute leukemia.
Blood 1978;51(6):1051-6.
1978: P Ralph; H E Broxmeyer; Malcolm A S Moore; I Nakoinz
Induction of myeloid colony-stimulating activity in murine monocyte tumor cell lines by macrophage activators and in a T-cell line by concanavalin A.
Cancer research 1978;38(5):1414-9.
1978: N Mendelsohn; R R Eger; H E Broxmeyer; Malcolm A S Moore
Isolation of a granulocyte colony inhibitory factor derived from human polymorphonuclear neutrophils.
Biochimica et biophysica acta 1978;533(1):238-47.
1978: J I Kurland; F Traganos; Z Darzynkiewicz; Malcolm A S Moore
Macrophage-mediated cytostasis of neoplastic hemopoietic cells: cytofluorometric analysis of the reversible cell cycle block.
Cellular immunology 1978;36(2):318-30.
1978: Malcolm A S Moore; T M Dexter
Stem cell regulation in continuous hematopoietic cell culture.
Transplantation proceedings 1978;10(1):83-90.
1978: H E Broxmeyer; E Grossbard; N Jacobsen; Malcolm A S Moore
Evidence for a proliferative advantage of human leukemia colony-forming cells in vitro.
Journal of the National Cancer Institute 1978;60(3):513-21.
1978: J I Kurland; R S Bockman; H E Broxmeyer; Malcolm A S Moore
Limitation of excessive myelopoiesis by the intrinsic modulation of macrophage-derived prostaglandin E.
Science (New York, N.Y.) 1978;199(4328):552-5.
1978: N Williams; H Jackson; A P Sheridan; M J Murphy; A Elste; Malcolm A S Moore
Regulation of megakaryopoiesis in long-term murine bone marrow cultures.
Blood 1978;51(2):245-55.
1978: Malcolm A S Moore
The role of factors in differentiation of non-erythroid cells.
The symposium / The Society for Developmental Biology. Society for Developmental Biology. Symposium 1978;(35):181-8.
1978: R G Shah; S Green; Malcolm A S Moore
Colony stimulating and inhibiting activities in mouse serum after Corynebacterium parvum-endotoxin treatment.
Journal of the Reticuloendothelial Society 1978;23(1):29-41.
1977: J I Kurland; J W Hadden; Malcolm A S Moore
Role of cyclic nucleotides in the proliferation of committed granulocyte-macrophage progenitor cells.
Cancer research 1977;37(12):4534-8.
1977: R G Shah; L H Caporale; Malcolm A S Moore
Characterization of colony-stimulating activity produced by human monocytes and phytohemagglutinin-stimulated lymphocytes.
Blood 1977;50(5):811-21.
1977: J I Kurland; P W Kincade; Malcolm A S Moore
Regulation of B-lymphocyte clonal proliferation by stimulatory and inhibitory macrophage-derived factors.
The Journal of experimental medicine 1977;146(5):1420-35.
1977: T M Dexter; Malcolm A S Moore
In vitro duplication and "cure" of haemopoietic defects in genetically anaemic mice.
Nature 1977;269(5627):412-4.
1977: J Kurland; Malcolm A S Moore
Modulation of hemopoiesis by prostaglandins.
Experimental hematology 1977;5(5):357-73.
1977: A A Horland; Sandra R Wolman; M J Murphy; Malcolm A S Moore
Proliferation of erythroid colonies in semi-solid agar.
British journal of haematology 1977;36(4):495-9.
1977: P W Kincade; Malcolm A S Moore; J Lifter
Functionally distinct stages in B-lymphocyte maturation.
Annales d'immunologie 1977;128C(4-5):753-61.
1977: T M Dexter; Malcolm A S Moore; A P Sheridan
Maintenance of hemopoietic stem cells and production of differentiated progeny in allogeneic and semiallogeneic bone marrow chimeras in vitro.
The Journal of experimental medicine 1977;145(6):1612-6.
1977: H E Broxmeyer; Malcolm A S Moore; P Ralph
Cell-free granulocyte colony inhibiting activity derived from human polymorphonuclear neutrophils.
Experimental hematology 1977;5(2):87-102.
1977: Malcolm A S Moore
In vitro culture studies in chronic granulocytic leukaemia.
Clinics in haematology 1977;6(1):97-112.
1977: J D Gabourel; Malcolm A S Moore; Grover C Bagby; G H Davies
Effect of sodium salicylate on human and mouse granulopoiesis in vitro.
Arthritis and rheumatism 1977;20(1):59-64.
1976: Malcolm A S Moore; J A Hansen; L K Everson; Richard J O'Reilly; R A Good
Hematologic analysis of clinical bone marrow grafting evaluated by in vitro cultures.
Transplantation proceedings 1976;8(4):647-54.
1976: W A Kagan; J A Ascensão; Rajendra Pahwa; J A Hansen; G Goldstein; E B Valera; G S Incefy; Malcolm A S Moore; R A Good
Aplastic anemia: presence in human bone marrow of cells that suppress myelopoiesis.
Proceedings of the National Academy of Sciences of the United States of America 1976;73(8):2890-4.
1976: Malcolm A S Moore
Regulatory role of macrophages in hemopoiesis.
Journal of the Reticuloendothelial Society 1976;20(1):89-91.
1976: P Ralph; Malcolm A S Moore; K Nilsson
Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines.
The Journal of experimental medicine 1976;143(6):1528-33.
1976: P W Kincade; P Ralph; Malcolm A S Moore
Growth of B-lymphocytes clones in semisolid culture is mitogen dependent.
The Journal of experimental medicine 1976;143(5):1265-70.
1976: J Ascensão; Rajendra Pahwa; W Kagan; J Hansen; Malcolm A S Moore; R Good
Aplastic anaemia: Evidence for an immunological mechanism.
Lancet 1976;1(7961):669-71.
1976: Malcolm A S Moore
Prediction of relapse and remission in AML by marrow culture criteria.
Nouvelle revue française d'hématologie; blood cells 1976;17(1-2):109-24.
1976: Malcolm A S Moore
Clinical utility of bone marrow culture.
Hämatologie und Bluttransfusion 1976;19():79-90.
1975: G R Johnson; Malcolm A S Moore
Role of stem cell migration in initiation of mouse foetal liver haemopoiesis.
Nature 1975;258(5537):726-8.
1975: P W Kincade; Malcolm A S Moore; R A Schlegel; J Pye
B lymphocyte differentiation from fetal liver stem cells in89 Sr-treated mice1.
Journal of immunology (Baltimore, Md. : 1950) 1975;115(5):1217-22.
1975: D Metcalf; Malcolm A S Moore
Growth and responsiveness of human granulocytic leukemic cells in vitro.
Bibliotheca haematologica 1975;(40):235-41.
1974: T M Dexter; R Schofield; L G Lajtha; Malcolm A S Moore
Studies on the mechanisms of chemical leukaemogenesis.
British journal of cancer 1974;30(4):325-31.
1974: Malcolm A S Moore; G Spitzer; N Williams; D Metcalf; J Buckley
Agar culture studies in 127 cases of untreated acute leukemia: the prognostic value of reclassification of leukemia according to in vitro growth characteristics.
Blood 1974;44(1):1-18.
1974: N Williams; Malcolm A S Moore; K Shortman; L Condon; B Pike; G J Nossal
Density separation and characterisation of human blood leucocytes, including T and B lymphocytes.
The Australian journal of experimental biology and medical science 1974;52(Pt 3):491-503.
1974: D Metcalf; Malcolm A S Moore; J W Sheridan; G Spitzer
Responsiveness of human granulocytic leukemic cells to colony-stimulating factor.
Blood 1974;43(6):847-59.
1974: Malcolm A S Moore; G Spitzer; D Metcalf; D G Penington
Monocyte production of colony stimulating factor in familial cyclic neutropenia.
British journal of haematology 1974;27(1):47-55.
1974: R J Ratzan; Malcolm A S Moore; A A Yunis
Effect of chloramphenicol and thiamphenicol on the in vitro colony-forming cell.
Blood 1974;43(3):363-9.
1974: Malcolm A S Moore; H Ekert; M G Fitzgerald; A Carmichael
Evidence for the clonal origin of chronic myeloid leukemia from a sex chromosome mosaic: clinical, cytogenetic, and marrow culture studies.
Blood 1974;43(1):15-22.
1973: Malcolm A S Moore; N Williams
Analysis of proliferation and differentiation of foetal granulocyte-macrophage progenitor cells in haemopoietic tissue.
Cell and tissue kinetics 1973;6(5):461-76.
1973: N Williams; Malcolm A S Moore
Sedimentation velocity characterisation of the cell cycle of granulocytic progenitor cells in monkey hemopoietic tissue.
Journal of cellular physiology 1973;82(1):81-92.
1973: Malcolm A S Moore; N Williams; D Metcalf
In vitro colony formation by normal and leukemic human hematopoietic cells: characterization of the colony-forming cells.
Journal of the National Cancer Institute 1973;50(3):603-23.
1973: Malcolm A S Moore; N Williams; D Metcalf
In vitro colony formation by normal and leukemic human hematopoietic cells: interaction between colony-forming and colony-stimulating cells.
Journal of the National Cancer Institute 1973;50(3):591-602.
1973: Malcolm A S Moore; D Metcalf
Cytogenetic analysis of human acute and chronic myeloid leukemic cells cloned in agar culture.
International journal of cancer. Journal international du cancer 1973;11(1):143-52.
1972: Malcolm A S Moore; N Williams
Physical separation of colony stimulating cells from in vitro colony forming cells in hemopoietic tissue.
Journal of cellular physiology 1972;80(2):195-206.
1972: M J Cline; Malcolm A S Moore
Embryonic origin of the mouse macrophage.
Blood 1972;39(6):842-9.
1972: Malcolm A S Moore; N Williams; D Metcalf
Purification and characterisation of the in vitro colony forming cell in monkey hemopoietic tissue.
Journal of cellular physiology 1972;79(2):283-92.
1971: H Janoshwitz; Malcolm A S Moore; D Metcalf
Density gradient segregation of bone marrow cells with the capacity to form granulocytic and macrophage colonies in vitro.
Experimental cell research 1971;68(1):220-4.
1971: N L Warner; Malcolm A S Moore
Defects in hematopoietic differentiation in NZB and NZC mice.
The Journal of experimental medicine 1971;134(2):313-34.
1970: Stephen J Haskill; Malcolm A S Moore
Two dimensional cell separation: comparison of embryonic and adult haemopoietic stem cells.
Nature 1970;226(5248):853-4.
1970: D Metcalf; Malcolm A S Moore
Factors modifying stem cell proliferation of myelomonocytic leukemic cells in vitro and in vivo.
Journal of the National Cancer Institute 1970;44(4):801-8.
1970: Malcolm A S Moore; T A McNeill; Stephen J Haskill
Density distribution analysis of in vivo and in vitro colony forming cells in developing fetal liver.
Journal of cellular physiology 1970;75(2):181-92.
1970: Stephen J Haskill; T A McNeill; Malcolm A S Moore
Density distribution analysis of in vivo and in vitro colony forming cells in bone marrow.
Journal of cellular physiology 1970;75(2):167-79.
1970: Malcolm A S Moore; D Metcalf
Ontogeny of the haemopoietic system: yolk sac origin of in vivo and in vitro colony forming cells in the developing mouse embryo.
British journal of haematology 1970;18(3):279-96.
1969: D Metcalf; Malcolm A S Moore; N L Warner
Colony formation in vitro by myelomonocytic leukemic cells.
Journal of the National Cancer Institute 1969;43(4):983-1001.
1966: J J Owen; Malcolm A S Moore; P M Biggs
Chromosome studies in Marek's disease.
Journal of the National Cancer Institute 1966;37(2):199-209.